{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":60,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":60,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c17a046801e7","filters":{"venue":"Therapeutic Advances in Neurological Disorders"}},"results":[{"id":"W3034546965","doi":"10.1177/1756286420932036","title":"Neurological manifestations and implications of COVID-19 pandemic","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Pandemic; Comorbidity; Neurology; Intensive care medicine; Stroke (engine); Coronavirus; Disease; Hyposmia; Pediatrics; Encephalopathy; Coronavirus disease 2019 (COVID-19); Internal medicine; Psychiatry; Infectious disease (medical specialty)","authors":[{"name":"Georgios Tsivgoulis","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Valeria Caso","is_ca":false},{"name":"Martin Köhrmann","is_ca":false},{"name":"Carlos A. Molina","is_ca":false},{"name":"Charlotte Cordonnier","is_ca":false},{"name":"Urs Fischer","is_ca":false},{"name":"Peter J. Kelly","is_ca":false},{"name":"Vijay K. Sharma","is_ca":false},{"name":"Amanda Chan","is_ca":false},{"name":"Ramin Zand","is_ca":false},{"name":"Amrou Sarraj","is_ca":false},{"name":"Peter D. Schellinger","is_ca":false},{"name":"Konstantinos Voumvourakis","is_ca":false},{"name":"Nikolaos Grigoriadis","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Sotirios Tsiodras","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06617230146732682,"gpt":0.4122730557635806,"spread":0.3461007542962538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002724177,0.0005842949,0.002010047,0.0002632379,0.0001001394,0.00001572436,0.0004713514,0.0004626103,0.00009890104],"category_scores_gemma":[0.00186364,0.0004166366,0.0003825424,0.0006891616,0.0008511738,0.0001183105,0.0002081108,0.001130632,0.00001486222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004607466,"about_ca_system_score_gemma":0.0003651522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005668077,"about_ca_topic_score_gemma":0.00002612311,"domain_scores_codex":[0.9965355,0.0007717967,0.0009370674,0.001012608,0.0002788451,0.0004642125],"domain_scores_gemma":[0.9929162,0.005572705,0.0004620037,0.0005540356,0.00002832857,0.0004666946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002315719,0.0002690073,0.02455595,0.008782916,0.00006242617,0.0001345351,0.00005685439,0.00004515886,0.000001531216,0.003234155,0.00001533145,0.9626105],"study_design_scores_gemma":[0.001073748,0.001634354,0.009326547,0.0002980699,0.0006841277,0.0004891612,0.000009674733,0.00008589395,1.674832e-8,0.02498902,0.9610581,0.0003512505],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005170458,0.9865526,0.001602311,0.007777755,0.00008993558,0.002740099,0.0000652606,0.0002167749,0.0004382021],"genre_scores_gemma":[0.006779153,0.981192,0.0003176806,0.0110754,0.00004766828,0.0004386092,0.00008142908,0.00005657492,0.00001146595],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9622593,"threshold_uncertainty_score":0.9998285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111513828","doi":"10.1177/1756286420978004","title":"COVID-19 and cerebrovascular diseases: a comprehensive overview","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Stroke (engine); Intracerebral hemorrhage; Disease; Intensive care medicine; Coagulopathy; Internal medicine; Subarachnoid hemorrhage","authors":[{"name":"Georgios Tsivgoulis","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Ramin Zand","is_ca":false},{"name":"Vasileios Lioutas","is_ca":false},{"name":"Christos Krogias","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Ashkan Shoamanesh","is_ca":true},{"name":"Vijay K. Sharma","is_ca":false},{"name":"Shima Shahjouei","is_ca":false},{"name":"Claudio Baracchini","is_ca":false},{"name":"Charalambos Vlachopoulos","is_ca":false},{"name":"Rossetos Gournellis","is_ca":false},{"name":"Petros P. Sfikakis","is_ca":false},{"name":"Else Charlotte Sandset","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Sotirios Tsiodras","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05047681182604093,"gpt":0.3874367768063144,"spread":0.3369599649802735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001541156,0.001003961,0.003660218,0.000254783,0.0001193022,0.00004176742,0.0005326914,0.000457065,0.0002396278],"category_scores_gemma":[0.001518464,0.0007096633,0.0008864491,0.0007701694,0.0007772853,0.0001803342,0.0003643213,0.001209432,0.00005392125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001287267,"about_ca_system_score_gemma":0.0006158173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001156092,"about_ca_topic_score_gemma":0.0000129087,"domain_scores_codex":[0.9952772,0.001174484,0.0008393718,0.001488265,0.0005427934,0.000677939],"domain_scores_gemma":[0.993879,0.003811427,0.0003617523,0.0007816607,0.00002875591,0.001137431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002391672,0.000263988,0.001626304,0.06429674,0.0002460341,0.0003746341,0.00005192048,0.00002979871,9.915785e-8,0.0009009871,0.00004463995,0.9319257],"study_design_scores_gemma":[0.002197987,0.00112922,0.0008067793,0.001917944,0.001706628,0.0001706533,0.00001596367,0.00008550371,9.173566e-9,0.007090481,0.9842591,0.0006196781],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000354375,0.9905494,0.0004081869,0.004086957,0.000191737,0.004226264,0.00005724698,0.0002841783,0.0001605278],"genre_scores_gemma":[0.0002594889,0.9600683,0.0001360036,0.03874511,0.0001056166,0.0004554146,0.0001096006,0.0001081618,0.00001228189],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9842145,"threshold_uncertainty_score":0.9995354,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103958324","doi":"10.1177/1756285611406166","title":"Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University; University of Toronto; Centre for Addiction and Mental Health","funders":"Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Melatonin; Neuroprotection; Parkinson's disease; Medicine; Substantia nigra; Agomelatine; Circadian rhythm; Disease; Neuroscience; Melatonin receptor; REM sleep behavior disorder; Sleep (system call); Pharmacology; Internal medicine; Psychology; Hippocampus; Antidepressant","authors":[{"name":"Venkatramanujam Srinivasan","is_ca":false},{"name":"Daniel P. Cardinali","is_ca":false},{"name":"U Srinivasan","is_ca":false},{"name":"Charanjit Kaur","is_ca":false},{"name":"Gregory M. Brown","is_ca":true},{"name":"D. Warren Spence","is_ca":true},{"name":"Rüdiger Hardeland","is_ca":false},{"name":"Seithikurippu R. Pandi‐Perumal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0242184085777944,"gpt":0.252517391484598,"spread":0.2282989829068036,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000146178,0.0002475059,0.0002908627,0.0002166876,0.00007273859,0.00001220277,0.0001722597,0.0001047003,0.00004337963],"category_scores_gemma":[0.0001002991,0.000205799,0.00005286867,0.0003799989,0.000352378,0.0002418632,0.00006124801,0.0004013865,0.000004283804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008313735,"about_ca_system_score_gemma":0.00001135631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008976092,"about_ca_topic_score_gemma":0.00002763095,"domain_scores_codex":[0.9979966,0.0003977248,0.0003229481,0.0006818836,0.0002089984,0.000391849],"domain_scores_gemma":[0.9993323,0.0002275773,0.0001186857,0.0001962468,0.000008644281,0.0001165141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005541373,0.001382145,0.2131028,0.0001164246,0.00001408143,0.0003290113,0.00107492,0.001541958,0.0246406,0.1330496,4.268817e-7,0.6192065],"study_design_scores_gemma":[0.001554091,0.001099207,0.9083536,0.00002187064,0.00002092823,0.00002457234,0.00003659991,0.007735169,0.005486957,0.07431838,0.001039124,0.0003094875],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876392,0.01020936,0.000216418,0.0004144564,0.0001526574,0.0005530497,0.000006718899,0.00004830305,0.0007597961],"genre_scores_gemma":[0.9881613,0.01083163,0.00001495015,0.0008908638,0.00001236824,0.0000580843,3.646924e-7,0.00002225489,0.000008128126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6952507,"threshold_uncertainty_score":0.8392239,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085475081","doi":"10.1177/1756285609102724","title":"Review: Therapy for Alzheimer's disease: how effective are current treatments?","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Memantine; Medicine; Tolerability; Disease; Rivastigmine; Alzheimer's disease; Cholinesterase; Neurotransmitter receptor; Intensive care medicine; Pharmacology; Donepezil; Internal medicine; Dementia; Receptor; Adverse effect","authors":[{"name":"Krista L. Lanctôt","is_ca":true},{"name":"Ryan D. Rajaram","is_ca":true},{"name":"Nathan Herrmann","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03884627347654957,"gpt":0.3714684075139778,"spread":0.3326221340374282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007111325,0.0003457466,0.0005191137,0.00007025484,0.00008106087,0.00001472509,0.0001312981,0.00004513677,0.00002531224],"category_scores_gemma":[0.0001183812,0.0002311298,0.0002819108,0.0002398311,0.0001162105,0.0001763466,0.00001299554,0.0001961352,0.000004065146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001257151,"about_ca_system_score_gemma":0.00002389589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":1.943751e-7,"about_ca_topic_score_gemma":0.000001680413,"domain_scores_codex":[0.998421,0.0001944312,0.0002255571,0.0006031609,0.0001839667,0.0003719522],"domain_scores_gemma":[0.9990456,0.0002844832,0.0001179143,0.0003150367,0.00005558031,0.000181352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003768738,0.002193077,0.03748242,0.0001434815,0.00005023594,0.00002422188,0.00001881557,0.00004069631,0.0001119465,0.0001482345,0.0003139118,0.9557042],"study_design_scores_gemma":[0.008043831,0.005282304,0.7360031,0.0006971182,0.0006107698,0.000008375379,0.00001431525,0.000400999,0.0001746154,0.01077614,0.2374532,0.0005352351],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1829641,0.7988388,0.0003679575,0.01364046,0.0001685232,0.00382098,0.00004112614,0.00009882014,0.00005923504],"genre_scores_gemma":[0.6232785,0.353171,0.00002469556,0.02278031,0.00008172765,0.000586197,0.00005042427,0.00001723116,0.000009955581],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.955169,"threshold_uncertainty_score":0.94252,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3025164808","doi":"10.1177/1756286420915005","title":"Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Adverse effect; Expanded Disability Status Scale; Cohort; Placebo; Incidence (geometry); Internal medicine; Population; Relapsing remitting; Magnetic resonance imaging; Gastroenterology; Pathology; Radiology; Immunology","authors":[{"name":"Ralf Gold","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Amit Bar‐Or","is_ca":false},{"name":"Robert J. Fox","is_ca":false},{"name":"Ludwig Kappos","is_ca":false},{"name":"Chongshu Chen","is_ca":false},{"name":"Becky Parks","is_ca":false},{"name":"Catherine Miller","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03160701660016953,"gpt":0.272147108999602,"spread":0.2405400923994324,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001915759,0.0002055831,0.0006027205,0.00009586117,0.00003931878,0.000004865157,0.0001039018,0.00007670588,0.00001336022],"category_scores_gemma":[0.00100346,0.0001526816,0.00004799738,0.0003812853,0.0006052891,0.0001073273,0.0001275589,0.000357124,6.063599e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008730706,"about_ca_system_score_gemma":0.00001957969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005111014,"about_ca_topic_score_gemma":0.0001017153,"domain_scores_codex":[0.9982857,0.000167859,0.000481995,0.0004320387,0.0003085785,0.0003238546],"domain_scores_gemma":[0.9984852,0.001009917,0.0001679877,0.0001610192,0.00005409429,0.0001217491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01365609,0.0003679945,0.8594969,0.000107066,0.00004626116,0.000003136296,0.0007012793,0.0004691826,0.0009835965,0.00003610069,9.004366e-7,0.1241315],"study_design_scores_gemma":[0.01854264,0.002616868,0.9759611,0.0001334019,0.00003677254,3.546013e-7,0.0001610112,0.002115353,0.00007218437,0.00008782133,0.0001398067,0.0001326174],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936242,0.0048945,0.0001498198,0.0003952335,0.00002478978,0.0007830209,0.00001819006,0.00002184933,0.00008846711],"genre_scores_gemma":[0.9903754,0.008714699,0.0004550516,0.0004011798,0.000006210936,0.00001804024,0.000007387006,0.00001993792,0.00000207829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1239989,"threshold_uncertainty_score":0.6226174,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167117206","doi":"10.1177/1756285614546855","title":"Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects","year":2014,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Fungal Plant Pathogen Control","field":"Agricultural and Biological Sciences","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Tolerability; Context (archaeology); Clinical trial; Intensive care medicine; Relapsing remitting; Alternative medicine; Investigational Drugs; Adverse effect; Pharmacology; Internal medicine; Fingolimod; Immunology; Pathology","authors":[{"name":"Jiwon Oh","is_ca":true},{"name":"Paul O’Connor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06633268888999329,"gpt":0.2972254118672915,"spread":0.2308927229772982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002815285,0.0004300871,0.001156089,0.00003073403,0.00006357476,0.00003116986,0.0005334183,0.0001908793,0.00001692724],"category_scores_gemma":[0.00005982276,0.0001230189,0.0002333567,0.0004044288,0.0001909229,0.0001168824,0.00003903628,0.0003198503,0.000003947281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001786869,"about_ca_system_score_gemma":0.000009216037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001048291,"about_ca_topic_score_gemma":0.0007361214,"domain_scores_codex":[0.9974633,0.0007903715,0.0005629543,0.0006060176,0.0002051087,0.0003722769],"domain_scores_gemma":[0.9967179,0.002801692,0.0002857679,0.0001413193,0.00001047711,0.00004283396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000768282,0.0003561786,0.003226588,0.0004313326,0.000005150885,0.000003272508,0.00004615281,0.000003197442,0.00002851294,0.00008287805,6.805376e-7,0.9957392],"study_design_scores_gemma":[0.0002986522,0.001796913,0.01987584,0.001038096,0.00007599239,0.000006226715,0.00002925759,0.00003918335,4.636536e-7,0.0005066141,0.9760765,0.0002562185],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01622179,0.9815152,0.00000105437,0.0003375733,0.0001730405,0.001657305,0.00004400114,0.00002113854,0.00002888448],"genre_scores_gemma":[0.05891248,0.9403385,0.000008651152,0.0001314964,0.0001843637,0.000401717,0.00001870727,0.000002535224,0.000001542434],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.995483,"threshold_uncertainty_score":0.5016566,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163670346","doi":"10.1177/1756285610391693","title":"Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Interferon beta-1a; Placebo; Randomized controlled trial; Gastroenterology; Quartile; Confidence interval; Interferon beta; Immunology; Pathology","authors":[{"name":"Bernard M.J. Uitdehaag","is_ca":false},{"name":"Cris S. Constantinescu","is_ca":false},{"name":"Peter Cornelisse","is_ca":false},{"name":"Douglas Jeffery","is_ca":false},{"name":"Ludwig Kappos","is_ca":false},{"name":"David Li","is_ca":true},{"name":"Magnhild Sandberg‐Wollheim","is_ca":false},{"name":"Anthony Traboulsee","is_ca":true},{"name":"E. Verdun","is_ca":false},{"name":"Víctor M. Rivera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1420817650018123,"gpt":0.3665192244154442,"spread":0.2244374594136319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003307248,0.000403703,0.0008404436,0.0002089429,0.00009258783,0.0000143557,0.0004394278,0.00008650582,0.00005281707],"category_scores_gemma":[0.0005451067,0.0002045922,0.0001861756,0.0005405737,0.0002967324,0.0002087225,0.0002072862,0.0005938194,0.000005238439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006091634,"about_ca_system_score_gemma":0.00002618236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001641677,"about_ca_topic_score_gemma":0.001467875,"domain_scores_codex":[0.9969512,0.0005886358,0.0006252887,0.0006601486,0.0006405357,0.0005341924],"domain_scores_gemma":[0.9977983,0.001148903,0.0002073679,0.000638721,0.00009203178,0.0001147164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01165488,0.003389635,0.9484299,0.00001140859,0.000248519,0.000005088903,0.004974636,0.0004899274,0.0002111631,8.322813e-7,0.000001644258,0.03058231],"study_design_scores_gemma":[0.007953675,0.01946918,0.9707966,0.000178441,0.00007285961,6.283792e-8,0.001219834,0.0000271687,0.00004686651,0.00004239092,0.000001488281,0.0001914046],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966894,0.0007663073,0.0001097739,0.0001250103,0.0001028113,0.002091706,0.00001831952,0.00004623163,0.00005045784],"genre_scores_gemma":[0.9987832,0.0004208249,0.0001235962,0.0003811562,0.0000128674,0.0002285308,0.000008112574,0.00003756067,0.00000411799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03039091,"threshold_uncertainty_score":0.8343027,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2944153925","doi":"10.1177/1756286419843458","title":"Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Mirabegron; Overactive bladder; Urinary incontinence; Quality of life (healthcare); Urinary urgency; Parkinson's disease; Visual analogue scale; Refractory (planetary science); Montreal Cognitive Assessment; Urinary system; Rating scale; Urology; Physical therapy; Internal medicine; Disease; Cognitive impairment","authors":[{"name":"Marilena Gubbiotti","is_ca":false},{"name":"Antonella Conte","is_ca":false},{"name":"Savino M. Di Stasi","is_ca":false},{"name":"Nicola Tambasco","is_ca":false},{"name":"Antonella Giannantoni","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03204323492826271,"gpt":0.3429366496495084,"spread":0.3108934147212457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002305914,0.0001838117,0.0004298416,0.0001089518,0.00001428378,0.00000330999,0.0001563825,0.00003497928,0.00009073772],"category_scores_gemma":[0.00005513397,0.0001080586,0.00005585447,0.0004291798,0.0001591633,0.00009996991,0.00002524603,0.0002350738,0.000002345053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004412793,"about_ca_system_score_gemma":0.0000320091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000947217,"about_ca_topic_score_gemma":0.0001506607,"domain_scores_codex":[0.9977476,0.0008168928,0.0003515355,0.0003966282,0.0003885932,0.0002987613],"domain_scores_gemma":[0.9989092,0.0005751356,0.00008731869,0.0003524915,0.00002908575,0.00004678173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01599685,0.03952922,0.9288856,0.00004747547,0.00002232514,0.00001076043,0.001035462,0.00008045704,0.0001265243,0.000007313465,0.000001070238,0.01425692],"study_design_scores_gemma":[0.009035543,0.04569656,0.9433188,0.00001336659,0.00002219948,2.102299e-7,0.0004068343,0.0001357333,0.00001324822,0.0009199797,0.0003539988,0.00008346928],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926524,0.002931403,0.00000220201,0.0002817711,0.00003132498,0.003785545,0.00002214838,0.000007997055,0.0002851799],"genre_scores_gemma":[0.9969332,0.002733329,0.000004297437,0.0001345122,0.000003295631,0.0001499835,0.00001813299,0.00001058517,0.00001272557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01443323,"threshold_uncertainty_score":0.4406503,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3157239883","doi":"10.1177/1756286420982134","title":"Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"NIHR Cambridge Biomedical Research Centre; Bayer HealthCare; National Institute for Health and Care Research; Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Internal medicine; Clinical trial; Randomized controlled trial; Immunology; Transplantation","authors":[{"name":"Alasdair Coles","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Ann Bass","is_ca":false},{"name":"Aaron Boster","is_ca":false},{"name":"D. A. S. Compston","is_ca":false},{"name":"Óscar Fernández","is_ca":false},{"name":"Eva Havrdová","is_ca":false},{"name":"Kunio Nakamura","is_ca":false},{"name":"Anthony Traboulsee","is_ca":true},{"name":"Tjalf Ziemssen","is_ca":false},{"name":"David Margolin","is_ca":false},{"name":"Xiaobi Huang","is_ca":false},{"name":"Nadia Daizadeh","is_ca":false},{"name":"Madalina Chirieac","is_ca":false},{"name":"Krzysztof Selmaj","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04590724287686678,"gpt":0.3464066050044256,"spread":0.3004993621275588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000186878,0.0001252604,0.0003859647,0.00004225963,0.00004151692,0.000003489581,0.0001265987,0.00007542332,0.00004111956],"category_scores_gemma":[0.001126217,0.00007789391,0.0001000902,0.0002864291,0.0005803653,0.00004582818,0.0001925204,0.0002958055,6.842783e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001142985,"about_ca_system_score_gemma":0.00004952146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001302587,"about_ca_topic_score_gemma":0.00005952339,"domain_scores_codex":[0.9983782,0.0002804192,0.0003933063,0.0003348135,0.0003883375,0.0002249613],"domain_scores_gemma":[0.9986596,0.0007631966,0.0001134872,0.0003515774,0.00007171384,0.00004043208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3477227,0.001760983,0.05559482,0.0003122738,0.0001271326,0.00003678634,0.002008301,0.0009735876,0.009869599,0.0006082974,0.00005326687,0.5809322],"study_design_scores_gemma":[0.06013605,0.001719101,0.9289615,0.0000857799,0.00003325904,0.000002531122,0.000247678,0.0001378696,0.0003121121,0.0005816043,0.007699183,0.00008336526],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895735,0.007630331,0.00001921241,0.0009284579,0.000117169,0.00069601,0.00001862057,0.00001227037,0.0010044],"genre_scores_gemma":[0.9827612,0.01676555,0.0001380868,0.0002566005,0.00002804646,0.0000128591,0.000004642122,0.000009252351,0.00002377042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8733667,"threshold_uncertainty_score":0.3176422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131043834","doi":"10.1177/1756285613476127","title":"Diagnosis and treatment of impulse control disorders in patients with movement disorders","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Impulse control; Medicine; Movement disorders; Impulsivity; Psychiatry; Parkinson's disease; Amantadine; Parkinsonism; Impulse control disorder; Antipsychotic; Disease; Internal medicine; Pathological; Schizophrenia (object-oriented programming)","authors":[{"name":"Tiago Mestre","is_ca":true},{"name":"Antonio P. Strafella","is_ca":true},{"name":"Teri Thomsen","is_ca":false},{"name":"Valerie Voon","is_ca":false},{"name":"Janis M. Miyasaki","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007107237729423374,"gpt":0.2430266283361677,"spread":0.2359193906067444,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003978042,0.0003411838,0.0005427803,0.0001525516,0.00004176959,0.000009674466,0.00008407,0.00008210757,0.0001372709],"category_scores_gemma":[0.00001677309,0.0002196402,0.000084933,0.0002392969,0.0002373164,0.0001847441,0.00002268009,0.000103749,0.000004650679],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004128053,"about_ca_system_score_gemma":0.00001705227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001783193,"about_ca_topic_score_gemma":0.0007458676,"domain_scores_codex":[0.9983513,0.0001084844,0.0003398857,0.0005110623,0.0002537754,0.0004354537],"domain_scores_gemma":[0.9992937,0.0001855237,0.0001150674,0.0002467021,0.00002127421,0.0001377737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009699425,0.003296309,0.6412594,0.0000173047,0.00005032275,0.000002110795,0.0000631817,0.0001680967,0.00000319635,0.00008419663,4.703965e-7,0.3540855],"study_design_scores_gemma":[0.0161216,0.006860541,0.9592372,0.00002562779,0.00008534696,1.568533e-7,0.00007129662,0.0004806459,0.000006845652,0.01551168,0.00140413,0.0001949072],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917875,0.004148078,0.0001338253,0.001127401,0.00004605556,0.002405729,0.00001895761,0.00003031288,0.0003021349],"genre_scores_gemma":[0.980906,0.01712319,0.000120432,0.0008149593,0.000005328725,0.0009789277,0.00001581204,0.00002670968,0.000008623117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3538906,"threshold_uncertainty_score":0.895667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2899137047","doi":"10.1177/1756286418804760","title":"Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Novartis Pharma; IC Design Education Center; Biogen; Ipsen; Novartis","keywords":"Fingolimod; Medicine; Multiple sclerosis; Pregnancy; Natalizumab; Intensive care medicine; Internal medicine; Immunology","authors":[{"name":"Yvonne Geissbühler","is_ca":false},{"name":"Jere Vile","is_ca":false},{"name":"Gideon Koren","is_ca":true},{"name":"Morgane Guennec","is_ca":false},{"name":"Helmut Butzkueven","is_ca":false},{"name":"Hugh H. Tilson","is_ca":false},{"name":"Thomas M. MacDonald","is_ca":false},{"name":"Kerstin Hellwig","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01914898633168949,"gpt":0.26108031739118,"spread":0.2419313310594906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002283981,0.0001420843,0.0001864095,0.00005312565,0.00002232698,0.000004713698,0.0001441898,0.00008832767,0.00002708528],"category_scores_gemma":[0.0001460961,0.000101763,0.00004070345,0.000135479,0.0001701141,0.00001507717,0.00004360165,0.00007907138,9.843748e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004216274,"about_ca_system_score_gemma":0.00001881827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005261773,"about_ca_topic_score_gemma":0.0002207058,"domain_scores_codex":[0.9987673,0.0001975428,0.0002209236,0.0003129925,0.0002861266,0.0002150686],"domain_scores_gemma":[0.9995471,0.00003664204,0.00008108892,0.0002156725,0.00009635912,0.00002318362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005103975,0.0002821384,0.9295086,0.00000617188,0.00001109669,1.16048e-7,0.00008763158,0.0007795783,0.001085825,0.00001008895,1.416376e-7,0.06771825],"study_design_scores_gemma":[0.003422445,0.0009706771,0.9933516,0.00002835408,0.00002383865,5.025215e-8,0.00002002089,0.0003480252,0.0009063259,0.0006825402,0.0001167928,0.0001293445],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950743,0.003981263,0.000332902,0.00002502719,0.00008983302,0.0003743654,0.000005975364,0.000006224425,0.0001100747],"genre_scores_gemma":[0.9990988,0.0003579955,0.0001890092,0.0002457524,0.00001853493,0.00006566734,0.000008771595,0.00001289423,0.000002613644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06758891,"threshold_uncertainty_score":0.4149776,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3037795043","doi":"10.1177/1756286420935019","title":"Expert opinion on the use of cladribine tablets in clinical practice","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Expert opinion; Cladribine; Clinical Practice; Alternative medicine; Intensive care medicine; Traditional medicine; Medical physics; Family medicine; Internal medicine; Pathology","authors":[{"name":"Per Soelberg Sørensen","is_ca":false},{"name":"Diego Centonze","is_ca":false},{"name":"Gavin Giovannoni","is_ca":false},{"name":"Xavier Montalbán","is_ca":true},{"name":"Daniel Selchen","is_ca":true},{"name":"Patrick Vermersch","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Bassem Yamout","is_ca":false},{"name":"Hashem Salloukh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3616787011441253,"gpt":0.5036940022402069,"spread":0.1420153010960816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008569019,0.0004893453,0.002330619,0.000168354,0.00004888215,0.0000161418,0.0004694146,0.0003431099,0.00007588428],"category_scores_gemma":[0.01131749,0.0002579186,0.000463197,0.0008519713,0.0007151378,0.0001820212,0.0002744649,0.002292654,0.00002403421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004156855,"about_ca_system_score_gemma":0.0001216111,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001415518,"about_ca_topic_score_gemma":0.00001820621,"domain_scores_codex":[0.9941015,0.002455021,0.001460044,0.0008203675,0.0006522749,0.0005108328],"domain_scores_gemma":[0.9822064,0.01649014,0.0004995503,0.0006334197,0.00005932486,0.0001111827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009168642,0.0008838128,0.0003255341,0.0008229889,0.00008589098,0.00003573492,0.00005057941,0.00003234436,3.903275e-7,0.000343305,0.000151957,0.9963506],"study_design_scores_gemma":[0.0008977058,0.001817546,0.001456408,0.002097782,0.00004567457,0.000006904665,0.00003949203,0.0002541602,7.939823e-8,0.0001404081,0.9930471,0.0001967178],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002815164,0.9874051,0.00005605864,0.009152743,0.0002701242,0.002468188,0.00001366259,0.00003685227,0.0005691389],"genre_scores_gemma":[0.0003802405,0.9924198,0.0003626467,0.006285862,0.0001227012,0.0003548502,0.00001792654,0.00004759547,0.000008335815],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9961539,"threshold_uncertainty_score":0.9999873,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125508314","doi":"10.1177/1756286420986727","title":"Real-world comparative safety and efficacy of tenecteplase <i>versus</i> alteplase in acute ischemic stroke patients with large vessel occlusion","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Tenecteplase; Medicine; Thrombolysis; Modified Rankin Scale; Stroke (engine); Fibrinolytic agent; Occlusion; Tissue plasminogen activator; Internal medicine; Anesthesia; Ischemia; Ischemic stroke; Myocardial infarction","authors":[{"name":"Klearchos Psychogios","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Georgios Magoufis","is_ca":false},{"name":"Apostolοs Safouris","is_ca":false},{"name":"Odysseas Kargiotis","is_ca":false},{"name":"Stavros Spiliοpoulos","is_ca":false},{"name":"Ermioni Papageorgiou","is_ca":false},{"name":"Aikaterini Theodorou","is_ca":false},{"name":"Konstantinos Voumvourakis","is_ca":false},{"name":"Elias Broutzos","is_ca":false},{"name":"Elefterios Stamboulis","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01186310991751156,"gpt":0.2901336311178049,"spread":0.2782705212002933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001124585,0.0002805428,0.0006208483,0.0001441972,0.00004689546,0.000006014834,0.0001320177,0.00007735884,0.0000595325],"category_scores_gemma":[0.00006007118,0.0002107786,0.00005760235,0.0005628578,0.0002550188,0.0001454817,0.0002060678,0.0004119117,0.000002012427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003604695,"about_ca_system_score_gemma":0.00003577432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000937044,"about_ca_topic_score_gemma":0.0002350758,"domain_scores_codex":[0.9981179,0.0001361874,0.0004377488,0.0005724154,0.0003300784,0.0004056703],"domain_scores_gemma":[0.9987902,0.0005831673,0.0001639348,0.0003192016,0.00005342573,0.00009007121],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03946665,0.003074233,0.9411176,0.0001235873,0.0002227281,0.000228366,0.0005075254,0.000690326,0.001880109,0.000425577,0.0001900018,0.01207323],"study_design_scores_gemma":[0.04022325,0.002375288,0.9160654,0.0001378036,0.0002661469,0.000006486077,0.0003754022,0.001352941,0.001318463,0.00006890485,0.03741612,0.000393766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880915,0.0009936354,0.0003179332,0.000571192,0.00007800255,0.0006722613,0.00005213598,0.00003695461,0.009186394],"genre_scores_gemma":[0.992275,0.005772048,0.0007239246,0.0009713647,0.000009154865,0.00001891086,0.00009584875,0.00001990428,0.00011383],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03722612,"threshold_uncertainty_score":0.8595302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164111830","doi":"10.1177/17562864211018561","title":"Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Meta-analysis; Parkinson's disease; Motor symptoms; Disease; Cannabis; Systematic review; Psychiatry; Neuroscience; MEDLINE; Physical medicine and rehabilitation; Intensive care medicine; Internal medicine; Psychology","authors":[{"name":"Susan J. Thanabalasingam","is_ca":true},{"name":"Brandan Ranjith","is_ca":true},{"name":"Robyn Jackson","is_ca":true},{"name":"Don Thiwanka Wijeratne","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1150643569412122,"gpt":0.3927733063084333,"spread":0.2777089493672211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005578217,0.0004633608,0.005915118,0.0002762846,0.00005411751,0.00003072419,0.000240265,0.0001385874,0.00007416309],"category_scores_gemma":[0.001108742,0.000227761,0.001301418,0.001176396,0.0003258378,0.0001032024,0.0001311149,0.0004324695,2.292933e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002211147,"about_ca_system_score_gemma":0.0001195669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001007198,"about_ca_topic_score_gemma":0.00008663099,"domain_scores_codex":[0.9965674,0.0009873649,0.00102673,0.0007058094,0.0003405913,0.0003720837],"domain_scores_gemma":[0.9979339,0.000915513,0.0003914805,0.000528348,0.00009503637,0.0001357401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001209949,0.0002545845,0.0001398377,0.917254,0.02155276,0.00002484678,0.00004798751,0.00003044752,1.010156e-7,0.0004198465,0.0000423547,0.06011227],"study_design_scores_gemma":[0.0003184997,0.0003095532,0.0005816052,0.008516315,0.3697806,0.00001043413,0.00001930272,0.000349736,2.502007e-8,0.0001031701,0.6197469,0.0002639031],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002437333,0.9869612,0.00007251467,0.005443896,0.00001464631,0.007311632,0.0001588344,0.0000101974,0.000002637777],"genre_scores_gemma":[0.0003281599,0.9917637,0.00002072377,0.0016711,0.000006189514,0.005710857,0.00002641265,0.0000326859,0.0004401551],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9087377,"threshold_uncertainty_score":0.9287825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2405578566","doi":"10.1177/1756285616648060","title":"Quantitative analysis of multiple sclerosis patients’ preferences for drug treatment: a best–worst scaling study","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre for Advancing Health Outcomes; University of Saskatchewan; Sunnybrook Hospital; Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Multiple sclerosis; Drug; Preference; Latent class model; Logistic regression; Pharmacotherapy; Intensive care medicine; Internal medicine; Pharmacology; Psychiatry; Machine learning; Statistics","authors":[{"name":"Larry D. Lynd","is_ca":true},{"name":"Anthony Traboulsee","is_ca":true},{"name":"Carlo A. Marra","is_ca":true},{"name":"Nicole Mittmann","is_ca":true},{"name":"Charity Evans","is_ca":true},{"name":"Kathy H. Li","is_ca":true},{"name":"Melanie Carter","is_ca":true},{"name":"Celestin Hategekimana","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1248552293789991,"gpt":0.373623922066754,"spread":0.2487686926877549,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002419903,0.0002758739,0.000859395,0.0003852594,0.0001080452,0.000008893566,0.0001990803,0.00005586598,0.00005208586],"category_scores_gemma":[0.0008593316,0.0001467993,0.0002784241,0.0008873559,0.0004557175,0.0001652239,0.00006992221,0.00009760397,0.000003091731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004180279,"about_ca_system_score_gemma":0.00002042851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000745233,"about_ca_topic_score_gemma":0.001520903,"domain_scores_codex":[0.9977289,0.0002998466,0.0005229354,0.0006084162,0.0003896717,0.0004501954],"domain_scores_gemma":[0.9958721,0.003404782,0.0001831849,0.0003054931,0.0001479464,0.0000865074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002675937,0.003322304,0.7701064,0.00002143525,0.0006426023,4.633941e-7,0.0008964444,0.0002983432,0.0003362012,0.00003707119,7.80536e-7,0.221662],"study_design_scores_gemma":[0.007767411,0.008522354,0.9775127,0.00005632319,0.0006900706,3.216607e-8,0.001404897,0.002862857,0.00008757804,0.0006743768,0.0002480123,0.0001733864],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942565,0.001727151,0.001132566,0.0003888874,0.00005189281,0.00219437,0.0000942097,0.00003879601,0.0001156372],"genre_scores_gemma":[0.989614,0.009101178,0.0005143806,0.00008230246,0.000009845053,0.0006233689,0.0000120006,0.00001790625,0.00002500932],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2214886,"threshold_uncertainty_score":0.5986303,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405574148","doi":"10.1177/17562864241306684","title":"Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Multiple sclerosis; Medicine; Pathology; Neuroinflammation; Disease; Biomarker; Neuroscience; Bioinformatics; Immunology; Biology","authors":[{"name":"Assunta Dal‐Bianco","is_ca":false},{"name":"Jiwon Oh","is_ca":true},{"name":"Pascal Sati","is_ca":false},{"name":"Martina Absinta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2637609567356469,"gpt":0.4525095405371548,"spread":0.1887485838015078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005129788,0.0006365855,0.002321351,0.0004501365,0.00009998168,0.00002768888,0.0004043003,0.0006144161,0.00003594597],"category_scores_gemma":[0.001030951,0.0004266378,0.0004042229,0.0008446115,0.001840736,0.000142909,0.0003300924,0.002602548,0.00005662845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000163742,"about_ca_system_score_gemma":0.000291148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001430568,"about_ca_topic_score_gemma":0.0005837888,"domain_scores_codex":[0.9951848,0.0009824397,0.001270887,0.001475275,0.0003243055,0.0007623264],"domain_scores_gemma":[0.9960266,0.002949782,0.0002577823,0.0005600932,0.0000380743,0.0001676418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001455363,0.000355061,0.004145378,0.003257379,0.0001066653,0.00002890283,0.00003674325,0.000003144251,0.000002933927,0.00009636147,0.00001604113,0.9918059],"study_design_scores_gemma":[0.001824455,0.001289749,0.1332398,0.005922915,0.0005404777,0.00001433788,0.0001054537,0.0007213965,2.141179e-7,0.001064539,0.8547714,0.0005051807],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007033652,0.9944591,0.00003875378,0.001216142,0.0002588541,0.002848002,0.00004500655,0.0001160024,0.0003147621],"genre_scores_gemma":[0.02658445,0.9715827,0.00009980778,0.0002350495,0.0001491896,0.001200534,0.00003339806,0.00006814023,0.0000468099],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9913007,"threshold_uncertainty_score":0.9998186,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969905648","doi":"10.1177/1756285609336548","title":"Implementation of computer-based language therapy in aphasia","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Neurobiology of Language and Bilingualism","field":"Neuroscience","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Stroke Network","keywords":"Aphasia; Medicine; Intervention (counseling); Comprehension; Speech therapy; Audiology; Psychiatry; Linguistics","authors":[{"name":"Lisa M. D. Archibald","is_ca":true},{"name":"J. B. Orange","is_ca":false},{"name":"Donald J. Jamieson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02229337063971252,"gpt":0.3492101549210659,"spread":0.3269167842813534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001322743,0.0001613026,0.0002351128,0.0001450218,0.00002771969,0.000006973347,0.0002945444,0.00006672687,0.00007782124],"category_scores_gemma":[0.00002780795,0.0001243202,0.00006104922,0.0003727242,0.0001791651,0.0001234585,0.00001630364,0.0002106035,0.000002540056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005277271,"about_ca_system_score_gemma":0.0000146579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001381983,"about_ca_topic_score_gemma":0.00009656558,"domain_scores_codex":[0.9985047,0.0003368426,0.0003210177,0.0004010731,0.0001320302,0.0003043189],"domain_scores_gemma":[0.999321,0.000354839,0.0001095183,0.0001827028,0.000006387873,0.00002548458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000318643,0.0004713765,0.01599631,0.000005742486,8.751486e-7,0.0002071709,0.000581732,0.001055228,0.08418679,0.000480392,0.000001087945,0.8966947],"study_design_scores_gemma":[0.02801993,0.02824366,0.5336454,0.00007592872,0.00002323585,0.0001819592,0.002050557,0.009728924,0.3014791,0.08880889,0.00563879,0.00210365],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967123,0.001089263,0.0004962393,0.0009557998,0.00009548696,0.000355237,0.00000406462,0.00005344552,0.0002381127],"genre_scores_gemma":[0.988319,0.0009857448,0.0001594866,0.01049476,0.00001783203,0.0000112467,0.000002808472,0.000007320818,0.000001837981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.894591,"threshold_uncertainty_score":0.5069632,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394896461","doi":"10.1177/17562864241243186","title":"Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Chugai Pharmaceutical; Horizon Therapeutics; Genentech; Grifols; Mitsubishi Tanabe Pharma Corporation; Warszawski Uniwersytet Medyczny; CSL Behring; National Institute for Health and Care Research; Regeneron Pharmaceuticals; National Institutes of Health; UCB Pharma; Argenx; Cytokinetics; Japan Blood Products Organization; Union Chimique Belge; Alexion Pharmaceuticals; Patient-Centered Outcomes Research Institute; Biogen; Centers for Disease Control and Prevention; Muscular Dystrophy Association; Uniwersytet Warszawski; Momenta Pharmaceuticals; Sanofi; AstraZeneca; Myasthenia Gravis Foundation of America","keywords":"Medicine; Myasthenia gravis; Interim; Interim analysis; Open label; Term (time); Extension (predicate logic); Adverse effect; Clinical trial; Internal medicine; Law; Computer science","authors":[{"name":"James F. Howard","is_ca":false},{"name":"Saskia Bresch","is_ca":false},{"name":"Constantine Farmakidis","is_ca":false},{"name":"Miriam Freimer","is_ca":false},{"name":"Angela Genge","is_ca":true},{"name":"Channa Hewamadduma","is_ca":false},{"name":"John L. Hinton","is_ca":false},{"name":"Yessar Hussain","is_ca":false},{"name":"Raúl Juntas‐Morales","is_ca":false},{"name":"Henry J. Kaminski","is_ca":false},{"name":"Angelina Maniaol","is_ca":false},{"name":"Renato Mantegazza","is_ca":false},{"name":"Masayuki Masuda","is_ca":false},{"name":"Richard J. Nowak","is_ca":false},{"name":"Kumaraswamy Sivakumar","is_ca":false},{"name":"Marek Śmiłowski","is_ca":false},{"name":"Kimiaki Utsugisawa","is_ca":false},{"name":"Tuan Vu","is_ca":false},{"name":"Michael D. Weiss","is_ca":false},{"name":"Małgorzata Zajda","is_ca":false},{"name":"Jos Bloemers","is_ca":false},{"name":"Babak Boroojerdi","is_ca":false},{"name":"Melissa Brock","is_ca":false},{"name":"Guillemette de la Borderie","is_ca":false},{"name":"Petra W. Duda","is_ca":false},{"name":"Mark Vanderkelen","is_ca":false},{"name":"Maria Isabel Leite","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02397615723265628,"gpt":0.329973967553128,"spread":0.3059978103204717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002465661,0.0002247902,0.000751859,0.0002492988,0.0000375228,0.00001711848,0.0002995781,0.00006286216,0.00004846365],"category_scores_gemma":[0.00003838968,0.0001181928,0.00007639141,0.001178181,0.0002996498,0.000103167,0.0001879328,0.0002657429,4.599416e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001100615,"about_ca_system_score_gemma":0.00002029912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002942948,"about_ca_topic_score_gemma":0.0002596849,"domain_scores_codex":[0.9981675,0.0002981884,0.0005379644,0.0004880023,0.0002856048,0.0002227012],"domain_scores_gemma":[0.9991699,0.0002014742,0.0001342958,0.0004099627,0.00003593638,0.0000484584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008794877,0.002670768,0.9211267,0.00005531693,0.000259818,0.00001674139,0.0007858392,0.0003224464,0.0001124513,0.0001949779,3.159077e-7,0.06565972],"study_design_scores_gemma":[0.009136248,0.00344543,0.9847581,0.0001222216,0.0005074994,0.000001826815,0.00008123776,0.001332275,0.000005617285,0.0004370494,0.00005166801,0.0001207635],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949515,0.003148553,0.000147719,0.0002535231,0.00006314321,0.001356263,0.00001164288,0.00001752102,0.00005006109],"genre_scores_gemma":[0.9990007,0.0005935708,0.00004900379,0.0002826691,0.000004387436,0.00002307526,0.00001449641,0.00001943324,0.00001269086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06553896,"threshold_uncertainty_score":0.4819763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3162974988","doi":"10.1177/17562864211014389","title":"A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neuromyelitis optica; Medicine; Disease; Subclinical infection; Spectrum disorder; Magnetic resonance imaging; Multiple sclerosis; Intensive care medicine; Pediatrics; Pathology; Immunology; Radiology; Psychiatry","authors":[{"name":"Jacqueline M. Solomon","is_ca":true},{"name":"Friedemann Paul","is_ca":false},{"name":"Claudia Chien","is_ca":false},{"name":"Jiwon Oh","is_ca":true},{"name":"Dalia Rotstein","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06666058728059476,"gpt":0.4407415941948044,"spread":0.3740810069142096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001399362,0.0006509735,0.001858284,0.00009861183,0.0003004367,0.00003821253,0.0007810839,0.000199688,0.000132296],"category_scores_gemma":[0.001285402,0.0003002966,0.000939006,0.0007924485,0.00131211,0.0001154257,0.0002937158,0.001009358,0.000005212693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005953202,"about_ca_system_score_gemma":0.0005056835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000098459,"about_ca_topic_score_gemma":0.0002108219,"domain_scores_codex":[0.9942029,0.001960304,0.0009018354,0.0009231456,0.001313253,0.0006986353],"domain_scores_gemma":[0.9946333,0.003462907,0.0004031926,0.001153302,0.0002165246,0.000130771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000269833,0.0004561079,0.0005788694,0.002341189,0.0002363023,0.000005971504,0.0002076205,0.0003237198,2.063815e-7,0.001056867,0.00002894193,0.9944944],"study_design_scores_gemma":[0.002106015,0.0006309576,0.009930923,0.001046642,0.002408226,0.000007097641,0.0004012769,0.00166688,1.34541e-7,0.007893695,0.9735849,0.0003232199],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001955565,0.9728961,0.0004372986,0.0183963,0.0004391098,0.007338955,0.00006020205,0.00003928575,0.000197162],"genre_scores_gemma":[0.006677089,0.988718,0.00009380861,0.0008421107,0.0003569729,0.00312434,0.00008765596,0.00007585783,0.00002422017],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9941711,"threshold_uncertainty_score":0.9999449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3138369521","doi":"10.1177/1756286421998905","title":"Expanding indications for endovascular thrombectomy-how to leave no patient behind","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thrombolysis; Stroke (engine); Occlusion; Endovascular treatment; Standard of care; Radiology; Intensive care medicine; Surgery; Myocardial infarction; Cardiology","authors":[{"name":"Peter B. Sporns","is_ca":false},{"name":"Jens Fiehler","is_ca":false},{"name":"Johanna M. Ospel","is_ca":false},{"name":"Apostolοs Safouris","is_ca":false},{"name":"Uta Hanning","is_ca":false},{"name":"Urs Fischer","is_ca":false},{"name":"Mayank Goyal","is_ca":true},{"name":"Ryan McTaggart","is_ca":false},{"name":"Alex Brehm","is_ca":false},{"name":"Marios Psychogios","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04140725659822479,"gpt":0.3576794775090664,"spread":0.3162722209108416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001892998,0.0005914287,0.001918792,0.0002983338,0.00009690708,0.00003462653,0.0003907183,0.0002986822,0.0001437876],"category_scores_gemma":[0.0004694115,0.0004468702,0.0007381348,0.0004832975,0.000148256,0.00009616777,0.0002623081,0.0006462754,0.0000392216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009874735,"about_ca_system_score_gemma":0.00008865623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001414835,"about_ca_topic_score_gemma":0.000007203038,"domain_scores_codex":[0.9970354,0.000211429,0.0006419852,0.001063011,0.000408322,0.0006398892],"domain_scores_gemma":[0.9980146,0.0007564317,0.0002926837,0.000719148,0.00005947402,0.0001576376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005074174,0.0002830859,0.00007712863,0.002103079,0.000243857,0.00002838046,0.0001090887,0.00001616565,0.000001963704,0.0001735384,0.0004301309,0.9964828],"study_design_scores_gemma":[0.000741274,0.0009128641,0.00002921604,0.001504651,0.0008294358,0.00001946383,0.0000931602,0.00001982595,0.000002229234,0.0001942514,0.9952685,0.0003850808],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007132575,0.9831096,0.008471159,0.001014799,0.0003982662,0.004631452,0.00003601615,0.00009107905,0.002176304],"genre_scores_gemma":[0.0004956647,0.9911317,0.003010772,0.002299587,0.0001332482,0.002429198,0.0001984103,0.00008871035,0.0002127134],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9960977,"threshold_uncertainty_score":0.9997983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402890485","doi":"10.1177/17562864241281903","title":"Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Liraglutide; Semaglutide; Internal medicine; Mace; Overweight; Odds ratio; Diabetes mellitus; Type 2 diabetes; Placebo; Dulaglutide; Myocardial infarction; Population; Glucagon-like peptide 1 receptor; Endocrinology; Adverse effect; Obesity; Agonist; Receptor; Percutaneous coronary intervention","authors":[{"name":"Maria‐Ioanna Stefanou","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aikaterini Theodorou","is_ca":false},{"name":"Apostolοs Safouris","is_ca":false},{"name":"Urs Fischer","is_ca":false},{"name":"Peter J. Kelly","is_ca":false},{"name":"Jesse Dawson","is_ca":false},{"name":"Mira Katan","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Vaia Lambadiari","is_ca":false},{"name":"Sotirios Giannopoulos","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Gerasimos Siasos","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06532569228572091,"gpt":0.3519981919897024,"spread":0.2866724997039815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008478959,0.00104266,0.008182822,0.000290637,0.00006262141,0.00002473119,0.0002378627,0.000187076,0.0001226997],"category_scores_gemma":[0.0001075941,0.0003615253,0.001814506,0.00114445,0.0003776384,0.0001336878,0.0001523354,0.0004130514,0.000007218878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001010914,"about_ca_system_score_gemma":0.00007483629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008166599,"about_ca_topic_score_gemma":0.001247032,"domain_scores_codex":[0.994672,0.001689884,0.001341267,0.001186868,0.0005966389,0.0005133412],"domain_scores_gemma":[0.9972081,0.0008015996,0.0006573873,0.001159035,0.00003659855,0.0001372745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004839648,0.001034157,0.003630353,0.3561097,0.6107957,0.0001424813,0.0001504549,0.0000383537,1.280615e-8,0.00003966788,0.000004110809,0.02757099],"study_design_scores_gemma":[0.001786388,0.002222041,0.0004531509,0.01146069,0.9659539,0.000008585625,0.00008439146,0.0000529376,5.975019e-8,0.0001295506,0.01742703,0.0004213068],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002785259,0.9872574,0.00001538993,0.0002756531,0.00003642203,0.009388379,0.0001655069,0.00004407711,0.00003191655],"genre_scores_gemma":[0.004721816,0.990497,0.00008047996,0.0005613744,0.000009893245,0.00366509,0.0001000961,0.00006751413,0.0002967217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3551581,"threshold_uncertainty_score":0.9998837,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804885025","doi":"10.1177/1756286418774338","title":"Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Fingolimod; Medicine; Multiple sclerosis; Randomized controlled trial; Natalizumab; Relapsing remitting; Clinical trial; Internal medicine; Oncology; Immunology","authors":[{"name":"Bruce Cree","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Mark Cascione","is_ca":false},{"name":"Edward Fox","is_ca":false},{"name":"Ian M. Williams","is_ca":false},{"name":"Xiangyi Meng","is_ca":false},{"name":"Lesley Schofield","is_ca":false},{"name":"Nadia Tenenbaum","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1835123173007922,"gpt":0.4296725863407087,"spread":0.2461602690399164,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002292452,0.0003530223,0.00148958,0.000221882,0.0001652219,0.00001761249,0.0003198717,0.0001707392,0.0001452056],"category_scores_gemma":[0.004572982,0.0002361349,0.0003921394,0.0005942606,0.001522864,0.0001661285,0.0001359279,0.000632512,0.0000151312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002397502,"about_ca_system_score_gemma":0.00003920923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004303702,"about_ca_topic_score_gemma":0.0002172548,"domain_scores_codex":[0.9944722,0.002206318,0.001215347,0.0008044947,0.0007286344,0.0005729898],"domain_scores_gemma":[0.9925968,0.006178096,0.0003550371,0.0005969745,0.0001471696,0.0001259456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8281413,0.01482161,0.006475265,0.00002269006,0.0002285848,0.000002853704,0.0007483949,0.00003771679,0.0003434905,0.00005244479,0.00001623224,0.1491094],"study_design_scores_gemma":[0.9073664,0.07384894,0.01050665,0.0000577079,0.0001407078,3.404332e-7,0.0008935821,0.004989859,0.00004857463,0.0006809984,0.001254276,0.0002119875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990807,0.001063664,0.0004211206,0.0005813492,0.0006414575,0.005279418,0.000007708417,0.00009881994,0.001099452],"genre_scores_gemma":[0.9887744,0.009500186,0.0001808303,0.0007059575,0.0002069252,0.0005711864,0.000006243776,0.0000331366,0.0000211827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1488975,"threshold_uncertainty_score":0.9629301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390639097","doi":"10.1177/17562864231221324","title":"Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Modified Rankin Scale; Tenecteplase; Odds ratio; Meta-analysis; Thrombolysis; Randomized controlled trial; Confidence interval; Internal medicine; Stroke (engine); Fibrinolytic agent; Relative risk; Tissue plasminogen activator; Ischemic stroke; Ischemia; Myocardial infarction","authors":[{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Guillaume Turc","is_ca":false},{"name":"Michele Romoli","is_ca":false},{"name":"Aikaterini Theodorou","is_ca":false},{"name":"Robin Lemmens","is_ca":false},{"name":"Simona Sacco","is_ca":false},{"name":"Georgios Velonakis","is_ca":false},{"name":"Charalambos Vlachopoulos","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05182824086950986,"gpt":0.3710587875438052,"spread":0.3192305466742953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000638516,0.0006837029,0.006478591,0.0002690238,0.00003872188,0.00001913951,0.0005230922,0.0001593973,0.00006729472],"category_scores_gemma":[0.00009148979,0.0002477666,0.002617116,0.001060507,0.0002570914,0.00004525651,0.00007424665,0.0003812102,0.00000850221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004149328,"about_ca_system_score_gemma":0.00003090727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002966371,"about_ca_topic_score_gemma":0.000007349784,"domain_scores_codex":[0.9967697,0.0005361084,0.001247534,0.0007291902,0.0003481691,0.0003693349],"domain_scores_gemma":[0.9959475,0.0025195,0.000495548,0.0009738695,0.00002274831,0.0000408225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001885955,0.0009914835,0.000006586848,0.6361086,0.2555629,0.00008712769,0.0001924092,0.00001302769,0.000001074114,0.0001182551,0.0002260082,0.1065039],"study_design_scores_gemma":[0.0003619472,0.0006866116,0.000002833908,0.002383418,0.7443034,0.00002879298,0.00002560531,0.0001148316,1.337582e-7,0.00006128211,0.251871,0.0001601008],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000005876149,0.985873,0.0001416939,0.001894717,0.00002446554,0.01151282,0.000173235,0.00002789463,0.0003462603],"genre_scores_gemma":[0.0001413323,0.9905033,0.00009283976,0.001921552,0.00001205478,0.00660828,0.00005622954,0.00003997152,0.0006245143],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6337252,"threshold_uncertainty_score":0.9999974,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050439782","doi":"10.1177/1756285608101378","title":"Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Dopaminergic; Dopamine; Levodopa; Medicine; Neuroscience; Parkinson's disease; Stimulation; Dopamine receptor; Dopaminergic pathways; Disease; Pharmacology; Psychology; Internal medicine","authors":[{"name":"O.K. Sujith","is_ca":true},{"name":"Carol J. Lane","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02220645230705962,"gpt":0.3253167809701142,"spread":0.3031103286630545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001632555,0.0003242352,0.0005817084,0.0001342092,0.00006911532,0.00001212689,0.0001630138,0.0001032125,0.00006991335],"category_scores_gemma":[0.0001538917,0.0002349756,0.0001997655,0.0004490697,0.0001410348,0.0001625107,0.00001864574,0.0002950138,0.000009530048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002135225,"about_ca_system_score_gemma":0.00002374561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001982661,"about_ca_topic_score_gemma":0.0000148079,"domain_scores_codex":[0.9979852,0.0001784539,0.0004739621,0.0006434563,0.0001987913,0.0005201306],"domain_scores_gemma":[0.9990431,0.0003452258,0.0001113189,0.0003202802,0.00003340065,0.0001466968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005485779,0.00500875,0.2791297,0.0003236096,0.00002983148,0.0001346489,0.00003274914,0.004123034,0.0001111952,0.006112097,0.0001409511,0.6993676],"study_design_scores_gemma":[0.005416393,0.003458177,0.6729193,0.0001819729,0.0001407445,0.000002973994,0.00001061437,0.004475116,0.000001896256,0.2584778,0.05460483,0.0003101515],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4424739,0.4978677,0.003368194,0.04691095,0.0002619975,0.007106514,0.00003095525,0.0003094976,0.001670281],"genre_scores_gemma":[0.8480723,0.1041325,0.0001821098,0.04717571,0.0000212658,0.0003093889,0.00004314384,0.00001840543,0.00004520583],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6990575,"threshold_uncertainty_score":0.9582025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386939132","doi":"10.1177/17562864231194823","title":"Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"Sanofi","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Relapsing remitting; Topaz; Open label; Oncology; Internal medicine; Adverse effect; Intensive care medicine; Immunology","authors":[{"name":"Alasdair Coles","is_ca":false},{"name":"Anat Achiron","is_ca":false},{"name":"Anthony Traboulsee","is_ca":true},{"name":"B. Singer","is_ca":false},{"name":"Carlo Pozzilli","is_ca":false},{"name":"Celia Oreja‐Guevara","is_ca":false},{"name":"Gavin Giovannoni","is_ca":false},{"name":"Gıancarlo Comı","is_ca":false},{"name":"Mark S. Freedman","is_ca":true},{"name":"Tjalf Ziemssen","is_ca":false},{"name":"Débora Shiota","is_ca":false},{"name":"Andreea M. Rawlings","is_ca":false},{"name":"Alana T. Wong","is_ca":false},{"name":"Magdalena Chirieac","is_ca":false},{"name":"Xavier Montalbán","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193604849736968,"gpt":0.3608530358003331,"spread":0.2414925508266362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009402552,0.0002810095,0.0005348386,0.0001128967,0.0002091674,0.00006203316,0.0004787167,0.00008451637,0.0000182885],"category_scores_gemma":[0.001597625,0.000171786,0.00003296084,0.0009319347,0.0004958171,0.0002192375,0.0005938313,0.0007894406,0.000009273414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003589872,"about_ca_system_score_gemma":0.00003745014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004733756,"about_ca_topic_score_gemma":0.003617405,"domain_scores_codex":[0.9969689,0.000528202,0.0005401658,0.000839745,0.0005103578,0.0006126763],"domain_scores_gemma":[0.9950451,0.00423249,0.0001225272,0.0004834119,0.00002845214,0.00008803778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01752405,0.001390849,0.7048127,0.00001180429,0.00006844496,0.00007018915,0.002739724,0.001699861,0.000184924,0.00001935596,0.00003338054,0.2714447],"study_design_scores_gemma":[0.03106885,0.001834083,0.9578896,0.0001688859,0.00002699889,0.000001431867,0.001561271,0.005286077,0.00000184462,0.0002857949,0.001688074,0.0001871184],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919516,0.00199226,0.00002349436,0.003266353,0.00007209784,0.002165359,0.00003098475,0.00009606723,0.0004017116],"genre_scores_gemma":[0.9871072,0.01140693,0.0001714579,0.001048411,0.00003606752,0.0001366757,0.00001877004,0.00003186228,0.00004263744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2712576,"threshold_uncertainty_score":0.7005228,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318815070","doi":"10.1177/17562864221150329","title":"Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare; Taipei Medical University; Parkinsonfonden; National Taiwan University; National Taiwan University Hospital; Ministry of Science and Technology, Taiwan","keywords":"Medicine; Parkinson's disease; Internal medicine; Biomarker; Disease; Cohort; Alpha-synuclein; Oncology; Endocrinology; Biology","authors":[{"name":"Lung Chan","is_ca":false},{"name":"Chen‐Chih Chung","is_ca":false},{"name":"Yi‐Chen Hsieh","is_ca":false},{"name":"Ruey‐Meei Wu","is_ca":false},{"name":"Chien‐Tai Hong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01881479634039804,"gpt":0.2950570597293986,"spread":0.2762422633890005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002785027,0.0002136458,0.0003823935,0.00008463171,0.0001125418,0.00001453481,0.0001082349,0.00005207755,0.00002414596],"category_scores_gemma":[0.00008368504,0.0001227408,0.00007341932,0.0003177696,0.000403471,0.00009105603,0.0001048555,0.0001638001,0.000004555273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005324441,"about_ca_system_score_gemma":0.00001663437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006537062,"about_ca_topic_score_gemma":0.00001909819,"domain_scores_codex":[0.9984263,0.0002571153,0.0002652479,0.0004591516,0.0002953541,0.0002968353],"domain_scores_gemma":[0.9991954,0.0002990129,0.00009592835,0.0002563165,0.00001470635,0.0001386367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01162552,0.001488669,0.6115718,0.00009673092,0.000103028,0.0002438198,0.000641637,0.00005142208,0.0002574171,0.001978645,0.00000514243,0.3719361],"study_design_scores_gemma":[0.01672846,0.001977816,0.9459079,0.00004575602,0.000260934,0.00000627901,0.0007260434,0.006656127,0.00003235421,0.01494508,0.01253843,0.0001748499],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800639,0.01711188,0.00003494358,0.001154604,0.00008381877,0.001370008,0.000008293012,0.00007620845,0.00009638102],"genre_scores_gemma":[0.9913449,0.00805897,0.00004637763,0.0002109136,0.00001136918,0.0002393262,0.00000568143,0.00002127158,0.00006119243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3717613,"threshold_uncertainty_score":0.5005226,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889307958","doi":"10.1177/1756286418791143","title":"Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; London Health Sciences Centre; NeuroRx Research (Canada)","funders":"Genentech; Biogen","keywords":"Medicine; Tolerability; Multiple sclerosis; Dosing; Adverse effect; Clinical endpoint; Internal medicine; Incidence (geometry); Surgery; Clinical trial","authors":[{"name":"Scott D. Newsome","is_ca":false},{"name":"Thomas F. Scott","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Gereon Nelles","is_ca":false},{"name":"Serena Hung","is_ca":false},{"name":"Yue Cui","is_ca":false},{"name":"Shulian Shang","is_ca":false},{"name":"Maria L. Naylor","is_ca":false},{"name":"Marcelo Kremenchutzky","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1208132788406075,"gpt":0.3691826571197619,"spread":0.2483693782791544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006409251,0.0003608489,0.0008114231,0.0001348652,0.0001292484,0.00001459465,0.0005297835,0.0001044907,0.00005147307],"category_scores_gemma":[0.001497435,0.0002109547,0.0001418554,0.0004920366,0.001190742,0.0002021346,0.0003400399,0.0005956943,0.00001599744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003343064,"about_ca_system_score_gemma":0.00002222702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001744865,"about_ca_topic_score_gemma":0.004638803,"domain_scores_codex":[0.996516,0.0005858306,0.0008301297,0.0008525653,0.0005994024,0.0006160362],"domain_scores_gemma":[0.9955911,0.003159554,0.0002198978,0.0008525998,0.0001044959,0.00007234924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006266601,0.001397774,0.854881,0.00001499147,0.00005327897,0.00001267811,0.001189117,0.000152598,0.001082712,0.000008292235,0.000008600647,0.1349323],"study_design_scores_gemma":[0.007881563,0.003231503,0.9862785,0.0001296121,0.00003437164,7.084369e-7,0.0005370686,0.0008218404,0.0001100275,0.0003197689,0.0004710811,0.0001839358],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865677,0.005603502,0.0001844866,0.005415789,0.0001932483,0.001763177,0.00003257227,0.00006027699,0.0001792747],"genre_scores_gemma":[0.9895865,0.008263048,0.0001746781,0.001707925,0.00006393537,0.0001417461,0.00001203343,0.00002978018,0.00002035126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1347484,"threshold_uncertainty_score":0.8602482,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391053875","doi":"10.1177/17562864231218181","title":"Effect of altered gene expression in lipid metabolism on cognitive improvement in patients with Alzheimer’s dementia following fecal microbiota transplantation: a preliminary study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Research Foundation of Korea; National Research Foundation","keywords":"Dementia; Gut flora; Medicine; Montreal Cognitive Assessment; Cognitive decline; Feces; Transplantation; Microbiome; Clinical Dementia Rating; Internal medicine; Biology; Physiology; Immunology; Bioinformatics; Disease; Microbiology","authors":[{"name":"Jun‐Seob Kim","is_ca":false},{"name":"Hyelim Park","is_ca":false},{"name":"Jung Hwan Lee","is_ca":false},{"name":"Jongbeom Shin","is_ca":false},{"name":"Boram Cha","is_ca":false},{"name":"Kye Sook Kwon","is_ca":false},{"name":"Yong Woon Shin","is_ca":false},{"name":"Yerim Kim","is_ca":false},{"name":"YeoJin Kim","is_ca":false},{"name":"Jong Seok Bae","is_ca":false},{"name":"Ju-Hun Lee","is_ca":false},{"name":"Seok‐Jin Choi","is_ca":false},{"name":"Tae Jung Kim","is_ca":false},{"name":"Sang‐Bae Ko","is_ca":false},{"name":"Soo-Hyun Park","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007089060045650178,"gpt":0.2823228089757372,"spread":0.275233748930087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002037552,0.0002136544,0.0002635457,0.0001054692,0.00002613545,0.000008344811,0.0001215365,0.00009051417,0.000005989012],"category_scores_gemma":[0.000008384141,0.0001508953,0.00006102988,0.0001696462,0.0000566029,0.00001399716,0.0000382791,0.0001993829,8.430882e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005111451,"about_ca_system_score_gemma":0.0000184771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007290956,"about_ca_topic_score_gemma":0.0000791904,"domain_scores_codex":[0.9984747,0.000346282,0.0002999859,0.0004996714,0.0001134479,0.000265922],"domain_scores_gemma":[0.9996893,0.00009563813,0.0000534839,0.0001241811,0.000008979278,0.00002838246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0309528,0.003702006,0.5415574,0.0003221457,0.0003522887,0.00005240662,0.000989512,0.001318732,0.2697474,0.000006974127,0.000002505221,0.1509958],"study_design_scores_gemma":[0.01179896,0.03204955,0.907272,0.0002435311,0.0002805223,0.000001432991,0.0001041545,0.00006920953,0.04763653,0.00004582695,0.0001483339,0.0003498964],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889035,0.009378644,0.0001511807,0.00003182729,0.000162915,0.001325996,0.0000176866,0.000008653004,0.00001961011],"genre_scores_gemma":[0.9986607,0.0008791492,0.00004732066,0.000200555,0.0000156682,0.000113458,0.00006424812,0.00001815495,7.452171e-7],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3657146,"threshold_uncertainty_score":0.6153332,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4285250308","doi":"10.1177/17562864221099472","title":"Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Fondaparinux; Low molecular weight heparin; Internal medicine; Cochrane Library; Thrombosis; Randomized controlled trial; Meta-analysis; Dosing; Cohort study; Observational study; Venous thromboembolism","authors":[{"name":"Paraskevi C. Fragkou","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Maria‐Ioanna Stefanou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Vaia Lambadiari","is_ca":false},{"name":"Dimitrios Paraskevis","is_ca":false},{"name":"Elisabeth Andreadou","is_ca":false},{"name":"Dimitra Dimopoulou","is_ca":false},{"name":"Christina Zompola","is_ca":false},{"name":"Panagiotis Ferentinos","is_ca":false},{"name":"Theodoros I. Vassilakopoulos","is_ca":false},{"name":"Αναστασία Κοτανίδου","is_ca":false},{"name":"Petros P. Sfikakis","is_ca":false},{"name":"Sotirios Tsiodras","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02498888179868167,"gpt":0.3877964226678904,"spread":0.3628075408692087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002720324,0.0001802752,0.0004713209,0.0001518626,0.000103454,0.000005723849,0.0001659703,0.00004863846,0.00002423722],"category_scores_gemma":[0.002763556,0.0001474614,0.00005476445,0.0004032347,0.0006164423,0.00005482275,0.0003864275,0.0005162497,9.189013e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005270264,"about_ca_system_score_gemma":0.00005097868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000352702,"about_ca_topic_score_gemma":0.00003660229,"domain_scores_codex":[0.9979843,0.0004096146,0.0003623391,0.0005231954,0.0004097283,0.0003108563],"domain_scores_gemma":[0.9947998,0.004690423,0.00009035486,0.0002517811,0.0000192653,0.0001483859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008767039,0.002325484,0.9622357,0.0007445608,0.00003492802,0.00005768045,0.0001725539,0.003849159,0.0002467762,0.002079976,0.000003411596,0.02737299],"study_design_scores_gemma":[0.004191407,0.00257826,0.9432784,0.0000242834,0.00003301369,9.457265e-7,0.00002553092,0.002856722,0.00002118168,0.04603725,0.000818566,0.0001343776],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901476,0.003479931,0.0003263949,0.004571271,0.00003998559,0.001195245,0.000006156916,0.00002761609,0.0002057952],"genre_scores_gemma":[0.983862,0.004839955,0.00004598023,0.01096675,0.000003328561,0.0002571843,0.000007548657,0.00001288037,0.000004341977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04395728,"threshold_uncertainty_score":0.60133,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4382995246","doi":"10.1177/17562864231182934","title":"Cardiac therapies for Duchenne muscular dystrophy","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Muscular Dystrophy Canada; Alberta Innovates; Women and Children's Health Research Institute; Children's Health Research Institute","keywords":"Medicine; Duchenne muscular dystrophy; Dystrophin; Intensive care medicine; Disease; Bioinformatics; Cardiomyopathy; Exon skipping; Clinical trial; Muscular dystrophy; Genetic enhancement; Genome editing; CRISPR; Internal medicine; Heart failure; Exon; Gene","authors":[{"name":"Md Nur Ahad Shah","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03475826749725864,"gpt":0.3471559604144085,"spread":0.3123976929171499,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002500321,0.0006215986,0.00130452,0.0001243772,0.0001179718,0.00001774005,0.0006178036,0.0006624392,0.00001728624],"category_scores_gemma":[0.0001350644,0.0004760122,0.0009190082,0.0003040657,0.0003829817,0.000009611538,0.0001552833,0.0003910609,0.00002545111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007803275,"about_ca_system_score_gemma":0.00006978463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002870239,"about_ca_topic_score_gemma":0.00002067878,"domain_scores_codex":[0.9971762,0.0004561994,0.0005346712,0.001042597,0.0001297537,0.0006605321],"domain_scores_gemma":[0.9987749,0.0003059352,0.0002219903,0.000596613,0.00002891029,0.00007162537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002454187,0.0001346955,0.00003846002,0.002138166,0.0002531545,0.000002132781,0.00001435054,0.000136518,0.00003074718,0.0008647399,0.00007265771,0.996069],"study_design_scores_gemma":[0.0004346925,0.0008136891,0.00007328424,0.0001472182,0.0001758248,0.000001082272,0.0000240308,0.0000112067,0.000001033889,0.01120314,0.9866063,0.0005085203],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004661829,0.9964038,0.0005852372,0.00008075014,0.0005536257,0.001566646,0.00009738767,0.00007199043,0.000174352],"genre_scores_gemma":[0.000857741,0.996416,0.0001023316,0.0003716111,0.0002110928,0.001385578,0.0004459374,0.0001151866,0.00009450026],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9955605,"threshold_uncertainty_score":0.9997692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W145182321","doi":"10.1177/1756285608098359","title":"Review: Escalating immunotherapy of multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Natalizumab; Glatiramer acetate; Alemtuzumab; Multiple sclerosis; Mitoxantrone; Immunotherapy; Clinical trial; Disease; Intensive care medicine; Fingolimod; Oncology; Immunosuppression; Immunology; Internal medicine; Transplantation; Chemotherapy; Immune system","authors":[{"name":"Anthony Traboulsee","is_ca":true},{"name":"Virginia Devonshire","is_ca":true},{"name":"Joël Oger","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08269379223139042,"gpt":0.3385518491725664,"spread":0.2558580569411759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002640809,0.0002245795,0.0006598866,0.0001054838,0.0001054037,0.000002269894,0.000215836,0.00007624721,0.0001497237],"category_scores_gemma":[0.0006525566,0.0001627795,0.0001837269,0.0005061681,0.0006861428,0.0001313736,0.00008062406,0.0003933916,0.000009608471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001564518,"about_ca_system_score_gemma":0.00002571811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001647361,"about_ca_topic_score_gemma":0.00002058452,"domain_scores_codex":[0.9980313,0.000208541,0.0005398525,0.0003880032,0.0003924012,0.0004399414],"domain_scores_gemma":[0.9986218,0.0007292136,0.0001416987,0.0003656647,0.00006826252,0.00007339762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008964934,0.0006851364,0.5399066,0.0005049542,0.00004822669,0.000008585545,0.0001937705,0.0001784693,0.007833459,0.00003964134,0.000081274,0.4496233],"study_design_scores_gemma":[0.003615209,0.001172282,0.9696761,0.000731168,0.000020186,0.00001320926,0.00004956846,0.001463836,0.0003087946,0.0005423289,0.02217387,0.0002334739],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6556073,0.3366508,0.0007108775,0.002831666,0.0000962487,0.00147333,0.000007222408,0.0001151594,0.00250737],"genre_scores_gemma":[0.5691925,0.4279246,0.0005259254,0.002247647,0.00001274478,0.00006721311,0.000002481851,0.00001447309,0.00001244405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4493899,"threshold_uncertainty_score":0.6637957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3089064542","doi":"10.1177/1756286420954083","title":"Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Merz Pharmaceuticals","keywords":"Medicine; Dosing; Botulinum toxin; Rating scale; Physical medicine and rehabilitation; Essential tremor; Quality of life (healthcare); Grip strength; Weakness; Physical therapy; Anesthesia; Internal medicine; Psychology; Surgery","authors":[{"name":"Olivia Samotus","is_ca":true},{"name":"Mandar Jog","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03389466039749872,"gpt":0.3268518546039901,"spread":0.2929571942064914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001221303,0.0002092821,0.0006866121,0.0001047571,0.00007774639,0.00001066173,0.00006660178,0.00009533414,0.00002221882],"category_scores_gemma":[0.0001297404,0.0001546173,0.0002351181,0.0005741348,0.0001165722,0.00008817593,0.00002200337,0.0001212116,1.462563e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001026003,"about_ca_system_score_gemma":0.00001536297,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004778446,"about_ca_topic_score_gemma":0.00001551194,"domain_scores_codex":[0.9985971,0.00009342827,0.0003858842,0.000474596,0.0001534259,0.0002955916],"domain_scores_gemma":[0.9992094,0.0004075979,0.0001524848,0.00009716729,0.00004195381,0.00009140414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.006052738,0.001055953,0.04615466,0.0003982433,0.0005160489,0.00000880003,0.0002411299,0.009106105,0.003791422,0.0002552056,0.000005044139,0.9324147],"study_design_scores_gemma":[0.01158964,0.006893857,0.03172025,0.0000219883,0.001722441,0.000001939844,0.0001186737,0.908482,0.0002613844,0.03657494,0.002323133,0.0002897808],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6528541,0.002532684,0.3413469,0.001664385,0.00003596463,0.001444512,0.00004066058,0.00004852019,0.00003231882],"genre_scores_gemma":[0.9682449,0.0009800959,0.02783956,0.002778383,0.00002349501,0.0000946402,0.00001582149,0.00002033022,0.000002817177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9321249,"threshold_uncertainty_score":0.630511,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310782882","doi":"10.1177/17562864221139632","title":"Endovascular treatment for anterior circulation large-vessel occlusion ischemic stroke with low ASPECTS: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Modified Rankin Scale; Stroke (engine); MEDLINE; Systematic review; Ischemic stroke; Randomized controlled trial; Internal medicine; Clinical trial; Ischemia","authors":[{"name":"Apostolοs Safouris","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"István Szikora","is_ca":false},{"name":"Odysseas Kargiotis","is_ca":false},{"name":"George Magoufis","is_ca":false},{"name":"Klearchos Psychogios","is_ca":false},{"name":"Stavros Spiliοpoulos","is_ca":false},{"name":"Εlias Brountzos","is_ca":false},{"name":"Sándor Nardai","is_ca":false},{"name":"Nitin Goyal","is_ca":false},{"name":"Diana Aguiar de Sousa","is_ca":false},{"name":"Daniel Strbian","is_ca":false},{"name":"Valeria Caso","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04180377092369003,"gpt":0.3360274067380769,"spread":0.2942236358143869,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005269094,0.0008369876,0.007915465,0.0003721829,0.0001221291,0.00002147627,0.000295766,0.0001590512,0.0003639942],"category_scores_gemma":[0.0001183674,0.0004641559,0.002418939,0.0009001491,0.0001103583,0.0001048992,0.0001617855,0.0003845251,0.000002480292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001406413,"about_ca_system_score_gemma":0.00005587694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002672128,"about_ca_topic_score_gemma":0.00001256384,"domain_scores_codex":[0.9961688,0.0005341132,0.001147586,0.001155657,0.0004951729,0.0004986957],"domain_scores_gemma":[0.9974679,0.0007230032,0.000790373,0.0008931282,0.00002942378,0.00009613443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001898879,0.0008278079,0.00004231056,0.8123308,0.1385682,0.0001240334,0.00007029613,0.00006997013,8.231906e-7,0.00005577681,0.00001422754,0.04770592],"study_design_scores_gemma":[0.001046635,0.0008000045,0.000005113925,0.003887072,0.6197812,0.00006833652,0.00003570373,0.000164723,1.207761e-7,0.00001817074,0.3738484,0.0003444967],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001593352,0.9837311,0.003836466,0.0003176756,0.00002496097,0.01153364,0.0001263842,0.00007555828,0.0003383121],"genre_scores_gemma":[0.0004506194,0.9908311,0.0003149397,0.001992078,0.00001186217,0.005917534,0.0002723539,0.00007228387,0.0001371912],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8084437,"threshold_uncertainty_score":0.999781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2922749437","doi":"10.1177/1756286419835708","title":"Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Modified Rankin Scale; Confounding; Logistic regression; Stroke (engine); Odds ratio; Confidence interval; Internal medicine; Clinical trial; Surgery; Ischemic stroke; Ischemia","authors":[{"name":"Thomas R. Meinel","is_ca":false},{"name":"Johannes Kaesmacher","is_ca":false},{"name":"Pasquale Mordasini","is_ca":false},{"name":"Pascal J. Mosimann","is_ca":false},{"name":"Simon Jung","is_ca":false},{"name":"Marcel Arnold","is_ca":false},{"name":"Mirjam R. Heldner","is_ca":false},{"name":"Patrik Michel","is_ca":false},{"name":"Steven Hajdu","is_ca":false},{"name":"Marc Ribó","is_ca":false},{"name":"Manuel Requena","is_ca":false},{"name":"Christian Maegerlein","is_ca":false},{"name":"Benjamin Friedrich","is_ca":false},{"name":"Vincent Costalat","is_ca":false},{"name":"Amel Benali","is_ca":false},{"name":"Laurent Pierot","is_ca":true},{"name":"Matthias Gawlitza","is_ca":false},{"name":"Joanna D. Schaafsma","is_ca":true},{"name":"Vítor Mendes Pereira","is_ca":true},{"name":"Jan Gralla","is_ca":false},{"name":"Urs Fischer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02135443875503519,"gpt":0.3062179837653848,"spread":0.2848635450103496,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002725213,0.0002587934,0.0006867553,0.000145914,0.00002107001,0.000007395096,0.0005052353,0.0001046763,0.0003883794],"category_scores_gemma":[0.0003713846,0.00020833,0.00005835223,0.0003490644,0.00009030199,0.0001514543,0.0008131717,0.0003692509,0.00008640702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002851891,"about_ca_system_score_gemma":0.00001458562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004791337,"about_ca_topic_score_gemma":0.0000323692,"domain_scores_codex":[0.997731,0.0001100167,0.0005641395,0.0008860092,0.0003252047,0.0003836238],"domain_scores_gemma":[0.9980487,0.0005510885,0.0001096301,0.001159295,0.00001604309,0.0001152069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004573552,0.000451205,0.8705118,0.00009805182,0.00008893977,0.0000553347,0.0003167547,0.001502114,0.02027951,0.00002512395,0.00007809992,0.1020195],"study_design_scores_gemma":[0.02384728,0.002120339,0.7730044,0.0005499356,0.0003067358,0.00002105797,0.001869313,0.01239795,0.0007025839,0.0001827152,0.1840366,0.0009611023],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901987,0.002344816,0.0009426567,0.002364226,0.00008947346,0.0017462,0.00003843051,0.000046555,0.002228957],"genre_scores_gemma":[0.9928794,0.000885154,0.002900778,0.003012,0.00002387401,0.00002273689,0.00003847429,0.00002610132,0.0002115184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1839585,"threshold_uncertainty_score":0.8495453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4226062860","doi":"10.1177/17562864211058298","title":"Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"EMD Serono; MedDay Pharmaceuticals; Genentech; Serono Symposia International Foundation; Servier; Aristotle University of Thessaloniki; Pirogov Russian National Research Medical University; Medizinische Universität Wien; Rigshospitalet; Università degli Studi di Genova; Hebrew University of Jerusalem; Universität Wien; Queen Mary University of London; CSL Behring; Gentofte Hospital; Fresenius Medical Care North America; Five Prime Therapeutics; Ironwood Pharmaceuticals, Incorporated; Vertex Pharmaceuticals; Ottawa Hospital Research Institute; Bayer Vital; Bristol-Myers Squibb; Bundesministerium für Bildung und Forschung; Atara Biotherapeutics; Merck KGaA; Univerzita Karlova v Praze; Pfizer; Biogen; Celgene; Teva Pharmaceutical Industries; Sanofi; GW Pharmaceuticals; Università degli Studi di Napoli Federico II; Bayer HealthCare; Deutsche Forschungsgemeinschaft; Directorate for Biological Sciences; GlaxoSmithKline","keywords":"Cladribine; Medicine; Expert opinion; Vaccination; Coronavirus disease 2019 (COVID-19); Clinical Practice; Dosing; MEDLINE; Multiple sclerosis; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Pathology; Immunology; Disease; Infectious disease (medical specialty)","authors":[{"name":"Diego Centonze","is_ca":false},{"name":"Gavin Giovannoni","is_ca":false},{"name":"Le H. Hua","is_ca":false},{"name":"Celia Oreja‐Guevara","is_ca":false},{"name":"Daniel Selchen","is_ca":true},{"name":"Per Soelberg Sørensen","is_ca":false},{"name":"Patrick Vermersch","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Hashem Salloukh","is_ca":false},{"name":"Bassem Yamout","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3187153313532363,"gpt":0.5275843612080184,"spread":0.2088690298547822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001610055,0.0003693174,0.002092891,0.0002046162,0.00006574774,0.00002126565,0.0002275507,0.0003111446,0.00005623364],"category_scores_gemma":[0.02279512,0.0002017778,0.000288921,0.0006397048,0.000613494,0.0001930741,0.0002307236,0.001357626,0.000002148981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005933724,"about_ca_system_score_gemma":0.0001753244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003448931,"about_ca_topic_score_gemma":0.00005575205,"domain_scores_codex":[0.9935616,0.003629037,0.001210699,0.0007298536,0.0005088286,0.0003599465],"domain_scores_gemma":[0.9763496,0.02249903,0.000470101,0.0004878541,0.00007448727,0.0001189241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001516359,0.0006803052,0.000486941,0.001365461,0.00007463028,0.0000219722,0.00009076264,0.00008754666,9.413724e-8,0.000817231,0.00006583655,0.9947929],"study_design_scores_gemma":[0.00388306,0.0008011103,0.00241787,0.001161802,0.00006222111,0.00001592325,0.00006878308,0.0003658107,2.766629e-8,0.0002619314,0.9908025,0.0001589947],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003834007,0.9894888,0.0002038169,0.00756501,0.0002018095,0.002261431,0.000008868833,0.00002232473,0.0002096346],"genre_scores_gemma":[0.0004966178,0.9920327,0.000325778,0.006660449,0.00006421012,0.0003474217,0.00003432815,0.00002791043,0.00001058213],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9946339,"threshold_uncertainty_score":0.9854363,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168568690","doi":"10.1177/1756285614549554","title":"Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome","year":2014,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Interferon beta-1b; Placebo; Expanded Disability Status Scale; Magnetic resonance imaging; Internal medicine; McDonald criteria; Randomization; Clinical trial; Interferon beta-1a; Interferon beta; Gastroenterology; Pathology; Immunology; Radiology","authors":[{"name":"Mark S. Freedman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2568097306530227,"gpt":0.4393229827033321,"spread":0.1825132520503094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004847094,0.0006745897,0.003674199,0.000376828,0.00009620704,0.00002037503,0.001430747,0.000453843,0.00002024972],"category_scores_gemma":[0.009187701,0.0003197367,0.0006931429,0.001335274,0.001896334,0.0001299791,0.0004547982,0.00207495,0.000003706452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004783081,"about_ca_system_score_gemma":0.0002437342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004204284,"about_ca_topic_score_gemma":0.000455986,"domain_scores_codex":[0.9917204,0.002202445,0.003570168,0.0009947864,0.0007005624,0.0008116442],"domain_scores_gemma":[0.9242812,0.07305861,0.001422663,0.001024461,0.000123493,0.00008954343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006225182,0.001118941,0.1789659,0.003899455,0.0003132834,0.000005544709,0.000201514,0.000649119,0.000001188262,0.000028681,0.00000261178,0.8085886],"study_design_scores_gemma":[0.02665129,0.05870954,0.752049,0.1023334,0.002882443,0.0000641313,0.0005160352,0.006618444,6.406913e-7,0.001330623,0.04714332,0.001701162],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04885213,0.9422109,0.0009057102,0.001073521,0.0001162234,0.006731531,0.00005531167,0.00003097823,0.00002376952],"genre_scores_gemma":[0.4091775,0.5893065,0.0003807901,0.0003558457,0.00001242977,0.0007111016,0.00001141291,0.0000426442,0.000001860563],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8068874,"threshold_uncertainty_score":0.9999255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380785062","doi":"10.1177/17562864231180715","title":"Arterial stiffness and its influence on cerebral morphology and cognitive function","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alzheimer Society","keywords":"Arterial stiffness; Medicine; Pulse wave velocity; Cardiology; Hyperintensity; Internal medicine; Blood pressure; Dementia; Ambulatory blood pressure; Pulse pressure; Magnetic resonance imaging; Disease; Radiology","authors":[{"name":"Melanie Haidegger","is_ca":false},{"name":"Simon Lindenbeck","is_ca":false},{"name":"Edith Hofer","is_ca":false},{"name":"Christina Rodler","is_ca":false},{"name":"Robert Zweiker","is_ca":false},{"name":"Sabine Perl","is_ca":false},{"name":"Lukas Pirpamer","is_ca":false},{"name":"Markus Kneihsl","is_ca":false},{"name":"Simon Fandler‐Höfler","is_ca":false},{"name":"Thomas Gattringer","is_ca":false},{"name":"Christian Enzinger","is_ca":false},{"name":"Reinhold Schmidt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01798120612956853,"gpt":0.3056240441426175,"spread":0.287642838013049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001007548,0.0001152336,0.0002061106,0.00009241765,0.00005725536,0.00000676507,0.0000242274,0.00007825715,0.00002815045],"category_scores_gemma":[0.0001206594,0.00009328655,0.00004385362,0.0001960504,0.000125312,0.00009800584,0.00003055542,0.0001685399,0.00001724565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000003294428,"about_ca_system_score_gemma":0.00001305622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002145225,"about_ca_topic_score_gemma":0.000006060376,"domain_scores_codex":[0.9990497,0.0001273853,0.0001395007,0.0003283082,0.0001242129,0.0002309469],"domain_scores_gemma":[0.9996006,0.0001779966,0.000031154,0.00007503625,0.00001780009,0.00009745343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02589869,0.0003496763,0.07435019,0.0003079446,0.00008077549,0.0001255792,0.0001537579,0.000471788,0.001443964,0.002238068,0.000005280236,0.8945743],"study_design_scores_gemma":[0.003704445,0.0004375304,0.9840119,0.00002457794,0.00008109157,0.0000197004,0.00005328361,0.0007090562,0.0000043799,0.01033832,0.0005292209,0.00008642963],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993903,0.004414122,0.0001162705,0.0007043967,0.0001484431,0.0004592393,0.000005599152,0.00007906111,0.00016983],"genre_scores_gemma":[0.9943508,0.002712058,0.000002732431,0.002795307,0.00003542797,0.00006736798,0.00001748368,0.000008684806,0.00001016014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9096618,"threshold_uncertainty_score":0.3804115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2956892819","doi":"10.1177/1756286419860652","title":"Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Randomized controlled trial; Odds ratio; Thrombolysis; Clinical trial; Clinical equipoise; Stroke (engine); Population; Post-hoc analysis; Internal medicine; Physical therapy; Myocardial infarction","authors":[{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false},{"name":"Martin Köhrmann","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":false},{"name":"Lauri Soinne","is_ca":false},{"name":"Andrew D. Barreto","is_ca":false},{"name":"Travis Rothlisberger","is_ca":false},{"name":"Vijay K. Sharma","is_ca":false},{"name":"Robert Mikulík","is_ca":false},{"name":"Keith W. Muir","is_ca":false},{"name":"Christopher Levi","is_ca":false},{"name":"Carlos A. Molina","is_ca":false},{"name":"Maher Saqqur","is_ca":true},{"name":"Dimitris Mavridis","is_ca":false},{"name":"Θεοδώρα Ψαλτοπούλου","is_ca":false},{"name":"Milan R. Voško","is_ca":false},{"name":"Jochen B. Fiebach","is_ca":false},{"name":"Pitchaiah Mandava","is_ca":false},{"name":"Thomas A. Kent","is_ca":false},{"name":"Peter D. Schellinger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01854891062198567,"gpt":0.3288484960183792,"spread":0.3102995853963935,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006463166,0.0002083845,0.001053631,0.00009609356,0.00001862433,0.000008587607,0.000288771,0.0001562039,0.00008422337],"category_scores_gemma":[0.0000833013,0.0001660852,0.0004281756,0.0002112276,0.0002092817,0.0001304435,0.00002252207,0.0002933305,0.000006855652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000807501,"about_ca_system_score_gemma":0.00001322546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003424995,"about_ca_topic_score_gemma":0.00002554513,"domain_scores_codex":[0.9981936,0.000185524,0.0008231748,0.0003401384,0.0001344359,0.0003231176],"domain_scores_gemma":[0.9976854,0.001847639,0.0001029501,0.0003097228,0.0000108739,0.00004340451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6337051,0.003434519,0.00273492,0.0001357325,0.0008946219,0.000003594761,0.000600068,0.02867637,0.01143664,0.005396656,0.00001009134,0.3129717],"study_design_scores_gemma":[0.9247955,0.0009319211,0.0002745751,0.000012619,0.000251877,8.204742e-7,0.00005308052,0.04456217,0.0001776323,0.01629053,0.01230446,0.0003447868],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9629304,0.002752633,0.0305401,0.0001500575,0.0002251378,0.002455426,0.0000206202,0.00008532208,0.0008403214],"genre_scores_gemma":[0.9902701,0.008325143,0.0004673162,0.0001802445,0.00003259861,0.0006718981,0.00001463319,0.00002711254,0.00001093728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.312627,"threshold_uncertainty_score":0.6772756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2737414819","doi":"10.1177/1756285617722352","title":"Liver injury and glatiramer acetate, an uncommon association: case report and literature review","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alberta Innovates - Health Solutions; Biogen; Sanofi","keywords":"Medicine; Glatiramer acetate; Autoimmune hepatitis; Discontinuation; Liver injury; Magnetic resonance imaging; Liver function; Lesion; Multiple sclerosis; Liver biopsy; Past medical history; Hepatitis; Radiology; Gastroenterology; Internal medicine; Surgery; Biopsy; Immunology","authors":[{"name":"Núria Solà‐Valls","is_ca":false},{"name":"Elisa Pose","is_ca":false},{"name":"Yolanda Blanco","is_ca":false},{"name":"María Sepúlveda","is_ca":false},{"name":"Sara Llufriú","is_ca":false},{"name":"Pere Ginès","is_ca":false},{"name":"Albert Saiz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1752683675166538,"gpt":0.4995301537817736,"spread":0.3242617862651198,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001557905,0.0006059234,0.001557569,0.0001397225,0.0004655243,0.00008293946,0.0003089908,0.001284268,0.0000876886],"category_scores_gemma":[0.0003538782,0.0004706651,0.0001938081,0.0002801889,0.0003381349,0.0005542052,0.0001658423,0.00315688,0.000009725314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004980609,"about_ca_system_score_gemma":0.00005147602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001008205,"about_ca_topic_score_gemma":0.0001152403,"domain_scores_codex":[0.9951168,0.002573406,0.0007736964,0.0008715448,0.0001750893,0.0004894343],"domain_scores_gemma":[0.9974746,0.0008710623,0.0009498993,0.0004600099,0.00005173112,0.00019268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006725908,0.0001405571,0.0004851372,0.007773521,0.00007628931,0.006711375,0.00008494097,0.000002576243,2.81916e-7,0.0001154423,0.00002531128,0.9845173],"study_design_scores_gemma":[0.0003557425,0.000331818,0.00007599145,0.00249435,0.000578801,0.008825881,0.000005654408,0.0000856431,2.578982e-7,0.002100037,0.9846678,0.0004779992],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007464889,0.9951363,0.00001188944,0.0004381459,0.0007043032,0.001810786,0.00005836893,0.00008419875,0.00100956],"genre_scores_gemma":[0.001167771,0.9952675,0.00004696457,0.002744336,0.0001389695,0.0003234812,0.00006001261,0.00004149819,0.0002095199],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9846425,"threshold_uncertainty_score":0.9997745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402546568","doi":"10.1177/17562864241273036","title":"Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"EMD Serono; Schweizerische Multiple Sklerose Gesellschaft; F. Hoffmann-La Roche; Grifols; Fondazione Cariplo; Multiple Sclerosis Society; UCB Pharma; Argenx; Idorsia Pharmaceuticals; Amicus Therapeutics; Janssen Pharmaceuticals; Merck KGaA; Bristol-Myers Squibb; CSL Behring; Pfizer; Biogen; Celgene; H. Lundbeck A/S; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Regeneron Pharmaceuticals; Novo Nordisk; Teva Pharmaceutical Industries; Sanofi","keywords":"Medicine; Myasthenia gravis; Autoantibody; Placebo; Subgroup analysis; Internal medicine; Tyrosine kinase; Gastroenterology; Antibody; Immunology; Oncology; Pharmacology; Meta-analysis; Receptor; Pathology; Alternative medicine","authors":[{"name":"Ali A. Habib","is_ca":false},{"name":"Sabrina Sacconi","is_ca":false},{"name":"Giovanni Antonini","is_ca":false},{"name":"Elena Cortés‐Vicente","is_ca":false},{"name":"Julian Großkreutz","is_ca":false},{"name":"Zabeen Mahuwala","is_ca":false},{"name":"Renato Mantegazza","is_ca":false},{"name":"Robert M. Pascuzzi","is_ca":false},{"name":"Kimiaki Utsugisawa","is_ca":false},{"name":"John Vissing","is_ca":false},{"name":"Tuan Vu","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Marion Boehnlein","is_ca":false},{"name":"Bernhard Greve","is_ca":false},{"name":"Franz Woltering","is_ca":false},{"name":"Vera Bril","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01523250983793078,"gpt":0.2854096034517853,"spread":0.2701770936138545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004435439,0.0004142287,0.001498767,0.000543564,0.00007898943,0.00002335934,0.0002415382,0.0001071004,0.0000388474],"category_scores_gemma":[0.0000290402,0.0002329836,0.0002900789,0.001874866,0.0004522602,0.0001474135,0.00009305683,0.0004660949,3.850568e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003264795,"about_ca_system_score_gemma":0.00003959319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005240164,"about_ca_topic_score_gemma":0.000184511,"domain_scores_codex":[0.9969617,0.0004753543,0.0009424999,0.0007218453,0.0005068549,0.0003917787],"domain_scores_gemma":[0.9984641,0.0006432878,0.0002816684,0.0004447563,0.00008137063,0.00008478866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8896889,0.004825864,0.06220012,0.00004739364,0.001245755,0.00004727149,0.002205263,0.005702529,0.0003228699,0.0009781475,2.84559e-7,0.0327356],"study_design_scores_gemma":[0.537104,0.004790742,0.444657,0.0001434657,0.001753315,0.000001739137,0.0003524503,0.01065258,0.00002994355,0.0002313818,0.00004202505,0.000241358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876484,0.005928473,0.0006165325,0.0001503535,0.00007181343,0.005385865,0.00003201246,0.00003554343,0.0001309948],"genre_scores_gemma":[0.998872,0.0007105936,0.00004840543,0.0000956515,0.0000141903,0.0001886611,0.000027101,0.00003392442,0.000009422717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3824569,"threshold_uncertainty_score":0.9500794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889527974","doi":"10.1177/1756286418795085","title":"Peginterferon β-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing–remitting multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Biogen","keywords":"Medicine; Multiple sclerosis; Predictive value; Clinical disease; Magnetic resonance imaging; Internal medicine; Disease; Cardiology; Gastroenterology; Radiology; Immunology","authors":[{"name":"Douglas L. Arnold","is_ca":true},{"name":"Shulian Shang","is_ca":false},{"name":"Qunming Dong","is_ca":false},{"name":"Matthias Meergans","is_ca":false},{"name":"Maria L. Naylor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06831757290086274,"gpt":0.3485683056196654,"spread":0.2802507327188026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006236976,0.0002131178,0.0004927041,0.0001451063,0.00004949639,0.000005316598,0.0002037308,0.00004610309,0.000007291151],"category_scores_gemma":[0.001609333,0.0001341847,0.00004751397,0.0004183913,0.001352175,0.0002807895,0.0001840899,0.0003494979,6.011537e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004565285,"about_ca_system_score_gemma":0.00002519093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007174498,"about_ca_topic_score_gemma":0.0004463882,"domain_scores_codex":[0.9977825,0.0005318524,0.0003801453,0.0004436586,0.0004976449,0.0003642583],"domain_scores_gemma":[0.9971465,0.002199446,0.0001891716,0.0003193959,0.00009590408,0.00004959872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02124604,0.0009169514,0.9478219,0.0002460304,0.00002780856,0.000002730442,0.0008254411,0.0001116749,0.0007906666,0.000006731086,0.00000210742,0.02800188],"study_design_scores_gemma":[0.00392135,0.004646429,0.9889557,0.001052749,0.00002163893,1.057131e-7,0.0003175642,0.0007368809,0.00003352965,0.0001559475,0.00003949241,0.000118609],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931571,0.005282903,0.00003985009,0.0004443539,0.00004256116,0.0009895626,0.000006526805,0.00001112242,0.00002604946],"genre_scores_gemma":[0.9896675,0.009636345,0.0001805685,0.0003982572,0.00001426014,0.00008601738,0.000001226856,0.00001367369,0.000002130775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04113377,"threshold_uncertainty_score":0.5471894,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396242288","doi":"10.1177/17562864241246938","title":"Overview of systematic reviews comparing endovascular to best medical treatment for large-vessel occlusion acute ischaemic stroke: an umbrella review","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Randomized controlled trial; Modified Rankin Scale; Systematic review; Meta-analysis; MEDLINE; Confidence interval; Relative risk; Stroke (engine); Cochrane Library; Internal medicine; Physical therapy; Ischemic stroke; Ischemia","authors":[{"name":"Apostolοs Safouris","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Odysseas Kargiotis","is_ca":false},{"name":"Konstantinos I. Bougioukas","is_ca":false},{"name":"Klearchos Psychogios","is_ca":false},{"name":"Tatiana Sidiropoulou","is_ca":false},{"name":"Stavros Spiliοpoulos","is_ca":false},{"name":"Marios‐Nikos Psychogios","is_ca":false},{"name":"Georgios Magoufis","is_ca":false},{"name":"Guillaume Turc","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0994132575965261,"gpt":0.4083583960650873,"spread":0.3089451384685613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001110778,0.0004119807,0.001827746,0.0001531937,0.00005138386,0.00001324454,0.0004101246,0.0001242679,0.0001609188],"category_scores_gemma":[0.0003351094,0.0002607505,0.0004655766,0.0004568183,0.00008136974,0.0001357022,0.0001713563,0.0002721382,0.0000342193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007035574,"about_ca_system_score_gemma":0.00004688327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005900026,"about_ca_topic_score_gemma":0.00003158482,"domain_scores_codex":[0.9966835,0.0003720543,0.001137672,0.0007260983,0.0005873867,0.0004932872],"domain_scores_gemma":[0.9983908,0.0005006705,0.0001737427,0.0006872291,0.0000369958,0.000210586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001603219,0.004540157,0.005713086,0.5750723,0.001840343,0.000589654,0.0008850959,0.0002145822,0.001453847,0.007351048,0.00213226,0.3986044],"study_design_scores_gemma":[0.004762604,0.006883453,0.0003994442,0.09404774,0.004282683,0.0002015863,0.0001703423,0.02098314,0.00011152,0.0006315957,0.8668211,0.0007048585],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01897836,0.9475634,0.01819733,0.004480843,0.0003181338,0.009247568,0.00002651084,0.0001237381,0.001064152],"genre_scores_gemma":[0.1444471,0.8451055,0.001185883,0.007800124,0.00005711997,0.001134135,0.00004416977,0.00004770347,0.0001782161],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8646888,"threshold_uncertainty_score":0.9999844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392848466","doi":"10.1177/17562864241233044","title":"Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Research Manitoba; Multiple Sclerosis Trust; Multiple Sclerosis Society of Canada; Arthritis Society; Alexion Pharmaceuticals; Celgene; Biogen; Gemeinsame Bundesausschuss; Sanofi; U.S. Department of Defense","keywords":"Medicine; Multiple sclerosis; Observational study; Fingolimod; Disease; Proportional hazards model; Patient registry; Internal medicine; Adverse effect; Pediatrics; Emergency medicine; Immunology","authors":[{"name":"Alexander Stahmann","is_ca":false},{"name":"Elaine Craig","is_ca":false},{"name":"David Ellenberger","is_ca":false},{"name":"Firas Fneish","is_ca":false},{"name":"Niklas Frahm","is_ca":false},{"name":"Ruth Ann Marrie","is_ca":true},{"name":"Rod Middleton","is_ca":false},{"name":"Richard Nicholas","is_ca":false},{"name":"Jeff Rodgers","is_ca":false},{"name":"Clemens Warnke","is_ca":false},{"name":"Amber Salter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1704735167555629,"gpt":0.3773027207272071,"spread":0.2068292039716443,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003522759,0.0002584795,0.0003708825,0.0004416218,0.00008378393,0.00003732148,0.0001712389,0.0001000077,0.0001344228],"category_scores_gemma":[0.0003365233,0.0002011959,0.0001108315,0.0008439113,0.0001408091,0.0003625375,0.00008972445,0.000645728,0.00001380871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006993402,"about_ca_system_score_gemma":0.00003437598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009827407,"about_ca_topic_score_gemma":0.006586877,"domain_scores_codex":[0.9976626,0.00023881,0.0004639617,0.0006096957,0.0003944138,0.0006304922],"domain_scores_gemma":[0.9989127,0.0006566316,0.00004211513,0.0002657694,0.00002200516,0.0001007714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005859762,0.0005331649,0.864364,0.00008742774,0.00001030302,0.0000374599,0.0002961959,0.001839395,0.0001904987,0.0005017795,0.000001898592,0.1315519],"study_design_scores_gemma":[0.002664533,0.0002175531,0.9172684,0.0002188897,0.000007003273,6.02466e-7,0.00008833822,0.06878094,0.000004752293,0.009493616,0.00108302,0.0001723624],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707403,0.02076002,0.002376575,0.0043291,0.0001857146,0.00121386,0.00003584987,0.0001378313,0.0002208053],"genre_scores_gemma":[0.9627179,0.0356147,0.000107553,0.001007129,0.00004536897,0.0004304135,0.00003909962,0.00003358637,0.000004260318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1313795,"threshold_uncertainty_score":0.8204532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412808922","doi":"10.1177/17562864251351760","title":"Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Rheinische Friedrich-Wilhelms-Universität Bonn; University of Alberta; McGill University Health Centre; Merck KGaA; McGill University","keywords":"Cladribine; Multiple sclerosis; Medicine; Relapsing remitting; Fingolimod; Oncology; Internal medicine; Immunology","authors":[{"name":"Klaus Schmierer","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Frederik Barkhof","is_ca":false},{"name":"Xavier Montalbán","is_ca":false},{"name":"Anat Achiron","is_ca":false},{"name":"Andrew Chan","is_ca":false},{"name":"Suzanne Hodgkinson","is_ca":false},{"name":"Alexandre Prat","is_ca":true},{"name":"Letizia Leocani","is_ca":false},{"name":"Finn Sellebjerg","is_ca":false},{"name":"Patrick Vermersch","is_ca":false},{"name":"Hulin Jin","is_ca":false},{"name":"Laura Sponton","is_ca":false},{"name":"Anita Chudecka","is_ca":false},{"name":"Lidia A. Gardner","is_ca":false},{"name":"Nicola De Stefano","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0542154939765968,"gpt":0.3566189088339214,"spread":0.3024034148573246,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009019501,0.0002343529,0.0006799306,0.000120908,0.00008985838,0.0000136189,0.0002634028,0.0001248718,0.000008876074],"category_scores_gemma":[0.005477575,0.0001458723,0.00008742088,0.0005551076,0.0007270163,0.0000784536,0.0002802429,0.0007827608,0.000002057914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001489568,"about_ca_system_score_gemma":0.0000291635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001564899,"about_ca_topic_score_gemma":0.001096988,"domain_scores_codex":[0.9968797,0.0009301972,0.0008084165,0.0006669032,0.0003322402,0.000382555],"domain_scores_gemma":[0.9901758,0.009137514,0.000123349,0.0004611707,0.00004183784,0.00006032348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005523464,0.001567794,0.854551,0.00007520602,0.0000700546,0.00001704767,0.000422583,0.00008539348,0.0007296333,0.0002028894,0.00001097804,0.1367439],"study_design_scores_gemma":[0.01378832,0.001792914,0.9744524,0.0003264572,0.00006631163,2.454815e-7,0.0006763583,0.002658235,0.00003268204,0.00577065,0.0003241012,0.0001113793],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986388,0.008344567,0.0003173414,0.002318102,0.0002282126,0.00199719,0.00001294581,0.0000410068,0.0003526646],"genre_scores_gemma":[0.9753419,0.02329461,0.0003105467,0.0008833643,0.00002652475,0.0001101196,0.000004564057,0.00001402191,0.00001437078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1366326,"threshold_uncertainty_score":0.6557564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135190823","doi":"10.1177/1756286420987941","title":"Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"AbbVie Biotherapeutics; Biogen","keywords":"Medicine; Daclizumab; Multiple sclerosis; BETA (programming language); Relapsing remitting; Internal medicine; Oncology; Immunology; Monoclonal antibody; Antibody","authors":[{"name":"Ludwig Kappos","is_ca":false},{"name":"Stanley Cohan","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Randy Robinson","is_ca":false},{"name":"Sami Fam","is_ca":false},{"name":"Becky Parks","is_ca":false},{"name":"Shan Xiao","is_ca":false},{"name":"Wanda Castro-Borrero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06762489834413932,"gpt":0.341432496039235,"spread":0.2738075976950957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005132228,0.0002226313,0.0006221178,0.0001992344,0.00008014643,0.00002669116,0.0002072841,0.00007653339,0.000004990526],"category_scores_gemma":[0.001087745,0.0001710613,0.00003508268,0.0007863368,0.0002125571,0.0003378592,0.0003138225,0.0004634106,5.666058e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004588732,"about_ca_system_score_gemma":0.00004076344,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008701748,"about_ca_topic_score_gemma":0.001192809,"domain_scores_codex":[0.9973274,0.0004928333,0.000628944,0.0006707203,0.0004739474,0.0004061366],"domain_scores_gemma":[0.9983788,0.001051314,0.0001343662,0.0003087583,0.00006472931,0.00006203094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01477425,0.004958198,0.8391606,0.00002774338,0.00002998978,0.00003297903,0.0009295724,0.0001583363,0.0001220467,0.00001187384,2.316247e-7,0.1397942],"study_design_scores_gemma":[0.06697048,0.003624896,0.9277015,0.0002797577,0.00002461019,4.313088e-7,0.0004721851,0.0006366945,0.00001178955,0.00009434193,0.00003575837,0.0001475112],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964972,0.0009578342,0.00002906365,0.0004416948,0.00004134967,0.001724281,0.00001187528,0.00001575357,0.0002810019],"genre_scores_gemma":[0.9974269,0.001773081,0.0005830571,0.0001035776,0.000004961255,0.0000610205,0.00001713769,0.00002014396,0.00001014883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1396466,"threshold_uncertainty_score":0.6975679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173363521","doi":"10.1177/17562864211021177","title":"A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Biogen","keywords":"Fingolimod; Medicine; Dimethyl fumarate; Propensity score matching; Internal medicine; Hazard ratio; Confidence interval; Multiple sclerosis; Relapsing remitting; Gastroenterology; Disease; Immunology","authors":[{"name":"Amber Salter","is_ca":false},{"name":"Samantha Lancia","is_ca":false},{"name":"Gary Cutter","is_ca":false},{"name":"Ruth Ann Marrie","is_ca":true},{"name":"Jason P. Mendoza","is_ca":false},{"name":"James B. Lewin","is_ca":false},{"name":"Robert Fox","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08033330319553018,"gpt":0.335826304475551,"spread":0.2554930012800208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001899777,0.0003328902,0.001069835,0.0000892145,0.00008084012,0.00001616089,0.000168931,0.00009863885,0.00007140428],"category_scores_gemma":[0.0004353386,0.0001898453,0.00006940302,0.0009996986,0.0008881738,0.0001905416,0.0001457411,0.0005384084,0.000001729713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005220376,"about_ca_system_score_gemma":0.00004999725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004501528,"about_ca_topic_score_gemma":0.003049671,"domain_scores_codex":[0.9971876,0.0004674525,0.000540018,0.0006999147,0.0005372468,0.0005677658],"domain_scores_gemma":[0.9982849,0.0008460922,0.0001767908,0.0004378547,0.0001488955,0.0001054757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01596845,0.003497645,0.9070178,0.0001735889,0.00006762551,0.0000229274,0.0003391616,0.001184553,0.0004364656,0.000002055699,2.797225e-7,0.07128945],"study_design_scores_gemma":[0.009506776,0.003099285,0.984953,0.0002692356,0.00004459764,0.000001114208,0.0001840117,0.001091242,0.0005950535,0.00001882242,0.00001752034,0.0002193017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997089,0.0008264144,0.0001746899,0.000379198,0.00001813225,0.001372905,0.000009390548,0.00005049358,0.00007981097],"genre_scores_gemma":[0.9981864,0.000898389,0.0005188552,0.0001742502,0.000006707501,0.0001409999,0.00003165832,0.00002977145,0.00001296601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07793524,"threshold_uncertainty_score":0.7741665,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392157493","doi":"10.1177/17562864231221331","title":"Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Health and Medical Research Council; Sanofi Genzyme; Grifols; Všeobecná Fakultní Nemocnice v Praze; Sanofi; European Commission; Canadian Institutes of Health Research; Multiple Sclerosis Australia; Teva Pharmaceutical Industries; Univerzita Karlova v Praze; Medical Research Council; Biogen; Celgene","keywords":"Natalizumab; Medicine; Multiple sclerosis; Disease; Fingolimod; First line therapy; Glatiramer acetate; Clinical significance; Teriflunomide; Intensive care medicine; Oncology; Internal medicine; Immunology","authors":[{"name":"Helmut Butzkueven","is_ca":false},{"name":"Tomáš Kalinčík","is_ca":false},{"name":"Francesco Patti","is_ca":false},{"name":"Mark Slee","is_ca":false},{"name":"Bianca Weinstock‐Guttman","is_ca":false},{"name":"Katherine Buzzard","is_ca":false},{"name":"Olga Skibina","is_ca":false},{"name":"Raed Alroughani","is_ca":false},{"name":"Alexandre Prat","is_ca":true},{"name":"Marc Girard","is_ca":true},{"name":"Dana Horáková","is_ca":false},{"name":"Eva Havrdová","is_ca":false},{"name":"Anneke van der Walt","is_ca":false},{"name":"Sara Eichau","is_ca":false},{"name":"Robert Hyde","is_ca":false},{"name":"Nolan Campbell","is_ca":false},{"name":"Karthik Bodhinathan","is_ca":false},{"name":"Tim Spelman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09250910395706537,"gpt":0.3612026078689723,"spread":0.268693503911907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003156686,0.0006220154,0.001182898,0.0002853972,0.0002117605,0.00009981995,0.0003429765,0.0001228429,0.00004776517],"category_scores_gemma":[0.0002640965,0.0003361497,0.0001531817,0.0008085016,0.001044911,0.0005138965,0.0001240177,0.001023527,0.000005413759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006180254,"about_ca_system_score_gemma":0.00007387856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002468594,"about_ca_topic_score_gemma":0.001711068,"domain_scores_codex":[0.9959839,0.0003913784,0.0007146555,0.001122473,0.0009324685,0.0008551087],"domain_scores_gemma":[0.9967231,0.002202411,0.0001953369,0.00053191,0.0001195397,0.000227677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01528655,0.001709092,0.8962026,0.000234288,0.0002793455,0.00008799367,0.000408957,0.001616752,0.000001784156,0.00001418101,0.000001823984,0.08415661],"study_design_scores_gemma":[0.01598152,0.003882892,0.9747562,0.001271071,0.00005307433,0.000001710651,0.0001669589,0.003101618,0.000001851189,0.0001095452,0.0002364773,0.0004370667],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831077,0.01155164,0.0006260621,0.002087466,0.0000833927,0.002183543,0.00004538833,0.0002374296,0.00007736928],"genre_scores_gemma":[0.977885,0.0198983,0.0002950717,0.001320504,0.00004207019,0.0004062331,0.0000455382,0.00009608681,0.00001115745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08371954,"threshold_uncertainty_score":0.999909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402546531","doi":"10.1177/17562864241273045","title":"The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Hotchkiss Brain Institute; University of Manitoba; Providence Health Care; University of British Columbia; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Toronto; Women and Children’s Health Research Institute; University of Alberta; Centre for Advancing Health Outcomes; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Horizon Therapeutics; U.S. Department of Defense; Sanofi; Government of Alberta; Fondation Brain Canada; Teva Pharmaceutical Industries; Biogen; University of Toronto; Biogen Idec; Eli Lilly and Company; Arthritis Society; International Progressive MS Alliance; Roche; University of Calgary","keywords":"Medicine; Multiple sclerosis; Prospective cohort study; Baseline (sea); Cohort; Internal medicine; Oncology; Immunology","authors":[{"name":"Jiwon Oh","is_ca":true},{"name":"Nathalie Arbour","is_ca":true},{"name":"Fabrizio Giuliani","is_ca":true},{"name":"Melanie Guenette","is_ca":true},{"name":"Shannon Kolind","is_ca":true},{"name":"Larry D. Lynd","is_ca":true},{"name":"Ruth Ann Marrie","is_ca":true},{"name":"Luanne M. Metz","is_ca":true},{"name":"Alexandre Prat","is_ca":true},{"name":"Alice Schabas","is_ca":true},{"name":"Penelope Smyth","is_ca":true},{"name":"Roger Tam","is_ca":true},{"name":"Anthony Traboulsee","is_ca":true},{"name":"V. Wee Yong","is_ca":true},{"name":"Scott B. Patten","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05701672225175849,"gpt":0.3518034886168417,"spread":0.2947867663650832,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039736,0.0002525706,0.0003788619,0.0002504463,0.0003140272,0.0001020406,0.0002313702,0.00006874452,0.00003023499],"category_scores_gemma":[0.001090177,0.0001501134,0.00005786867,0.0008640711,0.000354123,0.0001234871,0.0001091469,0.0007049757,0.00002223149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002453054,"about_ca_system_score_gemma":0.0001435032,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001570379,"about_ca_topic_score_gemma":0.3221714,"domain_scores_codex":[0.9973637,0.0003517248,0.0003997974,0.0006566848,0.0005249497,0.0007030873],"domain_scores_gemma":[0.9983622,0.001008888,0.00003284707,0.0003142253,0.00006335948,0.0002184102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007580274,0.0004567444,0.8421295,0.0000282929,0.00003610653,0.00005770655,0.0009333189,0.00008334923,0.00003977962,0.0001079586,0.0000160018,0.1553532],"study_design_scores_gemma":[0.001066487,0.001396979,0.9846057,0.0001293169,0.00001976296,0.000001575447,0.001212045,0.005976674,0.000004354561,0.0007815361,0.004648246,0.000157371],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758356,0.007280815,0.0002052487,0.009160329,0.0003063649,0.006207269,0.00001843724,0.0001225322,0.0008633608],"genre_scores_gemma":[0.991672,0.006824504,0.00006288067,0.0007283512,0.0000486809,0.0005894747,0.000005813936,0.00002984687,0.00003838294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.320601,"threshold_uncertainty_score":0.6901972,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411506045","doi":"10.1177/17562864251346326","title":"Therapeutic options for Duchenne muscular dystrophy: hope or hype?","year":2025,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Neurological Disorders","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Duchenne muscular dystrophy; Muscular dystrophy; Intensive care medicine; Neuroscience; Physical medicine and rehabilitation; Internal medicine; Psychology","authors":[{"name":"Jean K. Mah","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009820308100301598,"gpt":0.3000819553959397,"spread":0.2902616472956381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002604327,0.0006943071,0.0007332028,0.00014739,0.0002144386,0.00003335737,0.0009073979,0.001421848,0.00007315545],"category_scores_gemma":[0.0006644547,0.0005439263,0.0004228545,0.0002871944,0.0005252668,0.00001792632,0.0002083411,0.0008375743,0.000006670668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001707727,"about_ca_system_score_gemma":0.000284668,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001143796,"about_ca_topic_score_gemma":0.0002484795,"domain_scores_codex":[0.9966357,0.0003844854,0.0005524835,0.001352037,0.0002686823,0.0008065723],"domain_scores_gemma":[0.998001,0.0007693596,0.0002232865,0.0007899103,0.0001250595,0.00009137344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05983824,0.005224438,0.0009626016,0.002234388,0.001897304,0.00004660712,0.0001538535,0.02347303,0.01111893,0.008110185,0.3745474,0.512393],"study_design_scores_gemma":[0.002330484,0.002421776,0.0002686807,0.00002806653,0.0001288209,8.490869e-7,0.00003370164,0.0001632906,0.00003666171,0.02035548,0.9736173,0.0006149261],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"review","genre_scores_codex":[0.02073068,0.1758367,0.03831697,0.00334157,0.7491851,0.007573132,0.001384468,0.0003886896,0.003242709],"genre_scores_gemma":[0.3039654,0.3615964,0.002760751,0.01253972,0.2970163,0.007003438,0.00841083,0.0005820002,0.006125137],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.5990699,"threshold_uncertainty_score":0.9998745,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402696194","doi":"10.1177/17562864241276204","title":"Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Ibrutinib; Odds ratio; Ofatumumab; Internal medicine; Epilepsy; Oncology; Adverse Event Reporting System; Population; Discontinuation; Adverse effect; Rituximab; Psychiatry; Leukemia; Lymphoma; Chronic lymphocytic leukemia","authors":[{"name":"Afsaneh Shirani","is_ca":false},{"name":"Nil Saez-Calveras","is_ca":false},{"name":"Jack P. Antel","is_ca":true},{"name":"Moein Yaqubi","is_ca":true},{"name":"Wayne Moore","is_ca":true},{"name":"Amy L. Brewster","is_ca":false},{"name":"Olaf Stüve","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07818901370015804,"gpt":0.3082756776405036,"spread":0.2300866639403456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003473407,0.0001489083,0.0002367982,0.00008436095,0.00007870179,0.00002663157,0.0001009313,0.00004365398,0.000006295142],"category_scores_gemma":[0.0002327,0.00008203591,0.00007401202,0.0003106337,0.0002644873,0.0002268148,0.00004122673,0.0002334866,9.893108e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002772537,"about_ca_system_score_gemma":0.0001858547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000144332,"about_ca_topic_score_gemma":0.00005004484,"domain_scores_codex":[0.9987149,0.0001005407,0.0002215858,0.000329526,0.000317209,0.0003161965],"domain_scores_gemma":[0.997428,0.002255664,0.00005275724,0.0001720998,0.00003132756,0.00006016441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007907979,0.0003602041,0.3597562,0.001302463,0.0002590995,0.00002095792,0.00264613,0.002743503,0.001060644,0.003453611,0.00001720602,0.620472],"study_design_scores_gemma":[0.03120102,0.005394804,0.7014284,0.001329377,0.0005193353,0.00001921164,0.002377411,0.1868629,0.0008108579,0.0296205,0.03963174,0.0008044449],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772747,0.01767314,0.0007966526,0.003102535,0.0001252085,0.0008726407,0.000007668567,0.0000666965,0.00008074988],"genre_scores_gemma":[0.9839596,0.01510401,0.0001389911,0.0003158535,0.00005145261,0.0003756644,0.000003510863,0.00002546887,0.00002541339],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6196676,"threshold_uncertainty_score":0.3345327,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}